???global.info.a_carregar???
Luís Pereira de Almeida has been working since 1998 in gene/molecular therapy approaches for the Central Nervous System. In 2002 published one of the first papers showing that lentiviral vectors can be used to produce in vivo models of neurodegenerative diseases (e.g. Huntington's, Parkinson's, Machado-Joseph's disease), an approach on which his group specialized and that is now extensively used in the field (de Almeida LP et al The Journal of Neuroscience 2002). Professor at the Faculty of Pharmacy, University of Coimbra since 2003, coordinated the Masters in Pharmaceutical Biotechnology and the Doctoral Programme in Experimental Biology and Biomedicine, and teaches at graduate and undergraduate levels. His research activity is developed at CNC - Center for Neuroscience and Cell Biology of the University of Coimbra (Group Leader and President), and CIBB - Center for Innovative Biomedicine and Biotechnology (Coordinator). He spent short sabbatical leaves at CEA, Saclay in France (2005) and at the Massachussetts Institute of Technology (2010). The research of his group has been focused on molecular approaches for the study of the molecular mechanisms and advanced therapies for neurodegenerative disorders with a focus on Machado-Joseph disease/spinocerebellar ataxia type 3, including disease modifying and gene silencing approaches, autophagy activation and proteolysis inhibition, sirtuin-1 activation, etc, works published in over 100 papers and book chapters cited over thirteen thousand times, in journals such as Brain (5), Nature Communications, Cell Metabolism, Cell Reports, Acta Neuropathologica, Annals of Neurology, Human Molecular Genetics (6), Scientific Reports, PlosOne, awarded with prizes by Janssen Pharmaceutics, the Portuguese Society for Neurosciences (2009, 2011, 2012, 2013), the Portuguese Society of Human Genetics (2009), and Fundação Pulido Valente. Luis Pereira de Almeida has mentored 12 pos doctoral fellows and >20 PhD students and is or has been responsible for over 30 research projects funded by the Portuguese Foundation for Science and Technology, the Association Française de Myopathies, private funds, the National Ataxia Foundation (USA), the Center Region of Portugal and led one of the twelve European research groups that constitute the Marie Curie Initial Training Network “TreatPolyQ” within the 7th Framework Program of the European Union. His group integrates(ed) an iMi (EU Innovative Medicines Initiative) Project (Accelerating Research and Development in Advanced Therapies - ARDAT), an E-rare Eranet and 3 JPND european network projects, 2 of these - SynSpread and ModelPolyQ under his coordination. Bibliometric indicators: Publications: Books and book chapters : 9; Peer-reviewed papers: >100; Other: 43; Total 145; Publications Q1: 85%; Publications in Top 10%: 21; Conferences by invitation: >200; Communications in conferences by abstract submission: >300; PhD Thesis Commitees: 72; Principal opponent: 25; Citation Number (Google scholar): 13,000; h-index (Google scholar): 46; Atracted funding as PI: > 5 000 000; Evaluation by University of Coimbra (Research, Teaching, Technology transfer, University Management): (2014-2016) - Excelent. (2011-2013) - Excelent. Supervised 17 pos doctoral fellows, Supervised >20 PhD Students.
Identificação

Identificação pessoal

Nome completo
LUÍS FERNANDO MORGADO PEREIRA DE ALMEIDA

Nomes de citação

  • Pereira de Almeida, Luis
  • de Almeida, L
  • Almeida, L
  • Pereira de Almeida, L

Identificadores de autor

Ciência ID
5911-1D34-FB6B
ORCID iD
0000-0001-5831-3307
Google Scholar ID
https://scholar.google.com/citations?hl=en&user=uQzosFsAAAAJ
Researcher Id
A-4605-2009
Scopus Author Id
7005988619

Endereços de correio eletrónico

  • luispa@cnc.uc.pt (Profissional)
  • luispa@ci.uc.pt (Profissional)
  • luispa@ff.uc.pt (Profissional)

Moradas

  • University of Coimbra | Center for Neuroscience and Cell Biology | Rua Larga, 3004-504, Coimbra, Coimbra, Portugal (Profissional)

Websites

Domínios de atuação

  • Ciências Médicas e da Saúde - Biotecnologia Médica - Diagnóstico e Terapias de Base Genética
  • Ciências Médicas e da Saúde - Biotecnologia Médica - Biotecnologia Aplicada à Saúde
  • Ciências Médicas e da Saúde - Medicina Básica - Neurociências
  • Ciências Médicas e da Saúde - Biotecnologia Médica - Tecnologias que envolvem a Manipulação de Células,Tecidos,Órgãos ou todo o Organismo
  • Ciências Médicas e da Saúde - Medicina Clínica - Neurologia Clínica
  • Ciências Médicas e da Saúde - Medicina Básica - Genética Humana
  • Ciências da Engenharia e Tecnologias - Nanotecnologia
  • Ciências Médicas e da Saúde - Medicina Básica - Farmacologia e Farmácia
  • Ciências Médicas e da Saúde - Outras Ciências Médicas
  • Ciências Naturais - Ciências Biológicas
  • Ciências Médicas e da Saúde - Ciências da Saúde
  • Ciências Naturais - Ciências Biológicas - Biologia Molecular
  • Ciências Naturais - Ciências Biológicas - Biologia Celular

Idiomas

Idioma Conversação Leitura Escrita Compreensão Peer-review
Português Utilizador proficiente (C2) Utilizador proficiente (C2) Utilizador proficiente (C2) Utilizador proficiente (C2) Utilizador proficiente (C2)
Francês Utilizador proficiente (C2) Utilizador proficiente (C2) Utilizador proficiente (C2) Utilizador proficiente (C2) Utilizador proficiente (C2)
Inglês Utilizador proficiente (C2) Utilizador proficiente (C2) Utilizador proficiente (C2) Utilizador proficiente (C2) Utilizador proficiente (C2)
Espanhol; Castelhano Utilizador elementar (A1) Utilizador independente (B1) Utilizador elementar (A1) Utilizador elementar (A1) Utilizador elementar (A1)
Formação
Grau Classificação
2003
Concluído
Farmácia (Doutoramento)
Especialização em Especialidade: Tecnologia Farmacêutica
Universidade de Coimbra Faculdade de Farmácia, Portugal
"Lentiviral-based Gene Delivery Approaches for Therapeutic and Functional Studies in Huntington´s Disease" (TESE/DISSERTAÇÃO)
Percurso profissional

Ciência

Categoria Profissional
Instituição de acolhimento
Empregador
2019 - Atual Investigador Coordenador (carreira) (Investigação) CIBB - Center for Innovative Biomedicine and Biotecnology - Associated Laboratory, Portugal
CIBB - Center for Innovative Biomedicine and Biotecnology - Associated Laboratory, Portugal
1998/01/01 - 2001/04/03 Estagiário de Investigação (Investigação) Centre Hospitalier Universitaire Vaudois, Suiça

Docência no Ensino Superior

Categoria Profissional
Instituição de acolhimento
Empregador
2020/06 - Atual Professor Associado (Docente Universitário) University of Coimbra, Faculty of Pharmacy, Portugal
2003/02/22 - 2020 Professor Auxiliar (Docente Universitário) Universidade de Coimbra Faculdade de Farmácia, Portugal
2018 - 2019 Professor Auxiliar (Docente Universitário) Universidade de Coimbra, Portugal
2016 - 2018 Professor Auxiliar (Docente Universitário) Universidade de Coimbra, Portugal
2013 - 2016 Professor Auxiliar (Docente Universitário) Universidade de Coimbra Faculdade de Farmácia, Portugal
2013 - 2016 Professor Auxiliar (Docente Universitário) Universidade de Coimbra Faculdade de Farmácia, Portugal
2013 - 2016 Professor Auxiliar (Docente Universitário) Universidade de Coimbra Faculdade de Farmácia, Portugal
2003/02 - 2008/02 Professor Auxiliar (Docente Universitário) Universidade de Coimbra, Portugal
1996/01 - 2003/02 Assistente (Docente Universitário) Universidade de Coimbra, Portugal
1998/02 - 2001/04 Assistente (Docente Universitário) Universite de Lausanne, Suiça
1993/03 - 1996/01 Assistente Estagiário (Docente Universitário) Universidade de Coimbra, Portugal

Cargos e Funções

Categoria Profissional
Instituição de acolhimento
Empregador
2020/10/01 - Atual President of CNC Universidade de Coimbra, Portugal
CNC - Center for Neuroscience and Cell Biology, University of Coimbra, Portugal
2014/07/01 - 2020/10/01 Vice-Presidente Universidade de Coimbra Centro de Neurociências e Biologia Celular, Portugal
2018 - 2019 Coordenação ou direção de centro de investigação, departamento ou equivalente Universidade de Coimbra, Portugal
2017 - 2018 Coordenação ou direção de centro de investigação, departamento ou equivalente Universidade de Coimbra, Portugal
2013 - 2016 Conselho científico/técnico-científico ou orgão correspondente Universidade de Coimbra Faculdade de Farmácia, Portugal
2013 - 2016 Conselho científico/técnico-científico ou orgão correspondente Universidade de Coimbra Faculdade de Farmácia, Portugal
2013 - 2016 Conselho científico/técnico-científico ou orgão correspondente Universidade de Coimbra Faculdade de Farmácia, Portugal
1991/09/01 - 1993/05/31 Dirigente de laboratório, instituto, museu, centro ou observatório Laboratórios Delta - Rotta Research Group , Portugal
Laboratórios Delta - Rotta Research Group , Portugal

Outros

Categoria Profissional
Instituição de acolhimento
Empregador
2008/02/22 - Atual Nomeação definitiva | Tenure Universidade de Coimbra Faculdade de Farmácia, Portugal
Projetos

Bolsa

Designação Financiadores
2020/08/01 - Atual Fighting Sars-CoV-2 with Viral Vectors
CENTRO-01-01D2-FEDER-000002
Investigador responsável
Universidade de Coimbra, Portugal
Comissão de Coordenação e Desenvolvimento Regional do Centro
Em curso
2013 - Atual Viravector - Infrastructure of the national roadmap for production and research with viral vectors
CENTRO-01-0145-FEDER-022095
Investigador responsável
2020/11/01 - 2025/10/31 ARDAT - Accelerating research & development for advanced therapies- Innovative Medicines Initiative. EU Grant agreement number 945473. WP3 Co-lead.
945473
CNC - Center for Neuroscience and Cell Biology, University of Coimbra, Portugal
EU Framework Programme for Research and Innovation Societal Challenges
Em curso
2020/10/01 - 2023/06/30 ReSet – Development of a food supplement based on Resveratrol for optimal CNS activity
CENTRO-01-0247-FEDER-070162
CNC - Center for Neuroscience and Cell Biology, University of Coimbra, Portugal
Comissão de Coordenação e Desenvolvimento Regional do Centro
2018/01/07 - 2021/06/30 SpreadSilencing - Neurodegeneration blocking by genetic silencers dispersion, FCT-Portuguese Foundation for Science and Technology. POCI-01-0145-FEDER-029716. Principal investigator
POCI-01-0145-FEDER-029716
Investigador responsável
Fundação para a Ciência e a Tecnologia, I.P.
2016/09 - 2019/09 JPND European Spinocerebellar Ataxia Type 3/Machado-Joseph Disease Initiative
JPCOFUND/0001/2015
Universidade de Coimbra Centro de Inovação em Biomedicina e Biotecnologia, Portugal
Medical Research Council

Fundação para a Ciência e a Tecnologia
Concluído
2016/01 - 2018/12 Gene repair and repression strategies to alleviate Machado-Joseph disease Fundação para a Ciência e a Tecnologia
2013/03 - 2016/12 Machado-Joseph-Disease, protein aggregation, protein degradation, stem cell biology, proteostasis, neurodegeneration
Provided by PTCRIS: 132829PRJ
Fundação para a Ciência e a Tecnologia
2014/03 - 2015/09 Ageing@Coimbra: A Co-location Centre in the European Knowledge and Innovation Network for Active and Healthy Ageing Fundação para a Ciência e a Tecnologia
2012/04 - 2015/03 Non-invasive-Non-viral Silencing of Machado-Joseph disease
PTDC/SAU-FAR/116535/2010
Universidade de Coimbra Centro de Neurociências e Biologia Celular, Portugal
Fundação para a Ciência e a Tecnologia, I.P.

Fundação para a Ciência e a Tecnologia
Concluído
2011/03 - 2015/02 TreatPolyQ – Industrial Academic Initial Training Network towards treatment of Polyglutamine Diseases European Commission
2007/07 - 2010/12 Silencing Machado-Joseph disease: lentiviral-mediated RNA interference to ataxin-3
PTDC/SAU-FCF/70384/2006
Universidade de Coimbra Centro de Inovação em Biomedicina e Biotecnologia, Portugal
Fundação para a Ciência e a Tecnologia, I.P.

Fundação para a Ciência e a Tecnologia
Concluído
2005/09 - 2008/08 Transcription regulation by FK506 and BDNF control mitochondrial dependent cell death - a protective role in Huntington's disease
Provided by PTCRIS: 57310PRJ
POCI/SAU-NEU/57310/2004
Universidade de Coimbra Centro de Inovação em Biomedicina e Biotecnologia, Portugal
Fundação para a Ciência e a Tecnologia

Fundação para a Ciência e a Tecnologia
Concluído

Projeto

Designação Financiadores
2024/01 - 2029/12 GeneT - The Gene Therapy CoE at the Center of Portugal
Universidade de Coimbra Centro de Inovação em Biomedicina e Biotecnologia, Portugal

Universidade de Coimbra Centro de Neurociências e Biologia Celular, Portugal

Universidade de Coimbra, Portugal
2023/09/01 - 2026/08 NEURODIET - Mecanismos Moleculares de Intervenções Nutricionais na Neurodegenerescência (PT001)
JPND/0001/2022
ERA-NET JPco-fuND 2022
Investigador responsável
Universidade de Coimbra, Portugal

Universidade de Coimbra Centro de Inovação em Biomedicina e Biotecnologia, Portugal

Centro de Neurociências e Biologia Celular da Universidade de Coimbra, Portugal
Fundação para a Ciência e a Tecnologia
Em curso
2021/01/01 - 2025/12/31 Center for Innovative Biomedicine and Biotechnology - Associate Laboratory
LA/P/0058/2020
Universidade de Coimbra, Portugal
Fundação para a Ciência e a Tecnologia
Em curso
2023/01/01 - 2025/12 CInTech: Technological Hub for Innovation, Translation and Industrialization of Complex Injectable Drugs
Universidade de Coimbra, Portugal

Universidade de Coimbra Centro de Inovação em Biomedicina e Biotecnologia, Portugal

Universidade de Coimbra Centro de Neurociências e Biologia Celular, Portugal
2023/03/01 - 2024/08/31 Direct Conversion of Astrocytes into Cerebellar Neurons as an Innovative Treatment for Spinocerebellar Ataxia Type-3
2022.06127.PTDC
Universidade de Coimbra, Portugal
Fundação para a Ciência e a Tecnologia
Em curso
2023/03/01 - 2024/08/31 From “bedside-to-bench” biomarker discovery: on the road to a clinical trial for Machado-Joseph Disease
2022.06118.PTDC
Universidade de Coimbra, Portugal
Fundação para a Ciência e a Tecnologia
Em curso
2023/03/01 - 2024/08/31 Pre-clinical evaluation of the brain-targeting AAV-PHP.eB encoding cholesterol hydroxylase CYP46A1 as a therapeutic strategy for spinocerebellar ataxia type 3 – towards the understanding of the neuroprotective mechanism
2022.04788.PTDC
Universidade de Coimbra, Portugal
Fundação para a Ciência e a Tecnologia
Em curso
2023/02/01 - 2024/07/31 Exploring mitophagy to rescue neurological syndromes in mitochondrial diseases
2022.04458.PTDC
Rede de Química e Tecnologia Laboratório Associado para a Química Verde, Portugal
Fundação para a Ciência e a Tecnologia
Em curso
2021/03/01 - 2024/02/29 Assessing aging of human neurons by direct induced neuronal iN conversion
PTDC/MED-NEU/3890/2020
Universidade de Lisboa Instituto de Medicina Molecular João Lobo Antunes, Portugal

Universidade de Coimbra Centro de Inovação em Biomedicina e Biotecnologia, Portugal
Fundação para a Ciência e a Tecnologia
Em curso
2020/01/01 - 2023/12/31 Center for Innovative Biomedicine and Biotechnology
UIDP/04539/2020
Universidade de Coimbra, Portugal
Fundação para a Ciência e a Tecnologia
Em curso
2020/01/01 - 2023/12/31 Center for Innovative Biomedicine and Biotechnology
UIDB/04539/2020
Universidade de Coimbra, Portugal

Universidade de Coimbra Instituto de Investigação Clínica e Biomédica de Coimbra, Portugal

Universidade de Coimbra Centro de Neurociências e Biologia Celular, Portugal
Fundação para a Ciência e a Tecnologia
Concluído
2022/01/01 - 2023/06/30 Genome editing to rescue Machado-Joseph disease by alternative splicing
EXPL/MED-NEU/0936/2021
Universidade de Coimbra, Portugal

CNC.IBILI, Portugal
Fundação para a Ciência e a Tecnologia
Em curso
2018/07/26 - 2022/07/25 The ups and downs of cellular stress: the "MAM hypothesis" for Bipolar disorder pathophysiology
PTDC/MED-NEU/28214/2017
Universidade de Coimbra Centro de Inovação em Biomedicina e Biotecnologia, Portugal
Fundação para a Ciência e a Tecnologia
Em curso
2018/07/01 - 2022/06/30 Blocking neurodegeneration by spreading of gene silencers
PTDC/BTM-SAL/29716/2017
Universidade de Coimbra Centro de Inovação em Biomedicina e Biotecnologia, Portugal
Fundação para a Ciência e a Tecnologia
Em curso
2018/06/15 - 2022/06/14 The impact of induced pluripotent stem cells-derived neuroepithelial stem cells transplantation in Machado-Joseph disease.
PTDC/BTM-ORG/30737/2017
Universidade de Coimbra Centro de Neurociências e Biologia Celular, Portugal
Fundação para a Ciência e a Tecnologia
Concluído
2018/10/13 - 2022/04/12 The role of stress granules in Polyglutamine disease: from pathogenesis to molecular therapy
PTDC/MED-NEU/29480/2017
Universidade do Algarve, Portugal

Universidade de Coimbra Centro de Inovação em Biomedicina e Biotecnologia, Portugal
Fundação para a Ciência e a Tecnologia
Em curso
2018/07/06 - 2022/04/05 Role of microRNA deregulation in Machado-Joseph Disease: On the development of a microRNA-based therapeutic strategy
PTDC/MED-NEU/32309/2017
Universidade de Coimbra Centro de Inovação em Biomedicina e Biotecnologia, Portugal
Fundação para a Ciência e a Tecnologia
Em curso
2017/03/01 - 2022/03/31 ViraVerctor - Viral Vectors for Gene Transfer Core Facility
PINFRA/22095/2016
Universidade de Coimbra, Portugal
Fundação para a Ciência e a Tecnologia
Em curso
2018/06/01 - 2021/12/31 NiNjA - New Neuroendocrine Strategy for healthy Aging.
PTDC/MED-FAR/30167/2017
Universidade de Coimbra Centro de Inovação em Biomedicina e Biotecnologia, Portugal
Fundação para a Ciência e a Tecnologia
Concluído
2017/01/01 - 2021/06/30 Tackling CANcer STEM CELls: a challenge and an opportunity to advance in anti-cancer therapy
SAICTPAC/0022/2015
Universidade do Porto Instituto de Patologia e Imunologia Molecular, Portugal

Instituto Nacional de Engenharia Biomédica, Portugal

Fundação Calouste Gulbenkian, Portugal

Universidade de Coimbra, Portugal

Universidade de Coimbra Centro de Inovação em Biomedicina e Biotecnologia, Portugal
Fundação para a Ciência e a Tecnologia
Concluído
2016/04/01 - 2020/03/31 Advanced models of polyglutamine disorders
JPCOFUND/0005/2015
Universidade de Coimbra Centro de Inovação em Biomedicina e Biotecnologia, Portugal
Fundação para a Ciência e a Tecnologia
Concluído
2019/01/01 - 2019/12/31 CNC. IBILI
UID/NEU/04539/2019
Universidade de Coimbra, Portugal

Universidade de Coimbra Instituto de Investigação Clínica e Biomédica de Coimbra, Portugal

Universidade de Coimbra Instituto de Ciências Nucleares Aplicadas à Saúde, Portugal

Universidade de Coimbra Centro de Neurociências e Biologia Celular, Portugal
Fundação para a Ciência e a Tecnologia
Concluído
2016/06/01 - 2019/12/31 Imaging Gene Therapy in the Brain
PTDC/BBB-NAN/0932/2014
Universidade de Coimbra Centro de Inovação em Biomedicina e Biotecnologia, Portugal
Fundação para a Ciência e a Tecnologia
Concluído
2016/04/01 - 2019/12/31 Gene repair and repression strategies to alleviate Machado-Joseph disease
PTDC/NEU-NMC/0084/2014
Universidade de Coimbra Centro de Inovação em Biomedicina e Biotecnologia, Portugal
Fundação para a Ciência e a Tecnologia
Concluído
2016/05/01 - 2019/10/31 Control of cardiomyocyte proliferation in disease and regenerative medicine
PTDC/BIM-MED/3363/2014
Universidade Nova de Lisboa Faculdade de Ciências Médicas, Portugal

iNOVA4Health, Portugal

Universidade de Coimbra Centro de Inovação em Biomedicina e Biotecnologia, Portugal
Fundação para a Ciência e a Tecnologia
Concluído
2017/04/01 - 2019/06/30 NanoBiomateriais poliméricos para libertação de fármacos: Desenvolvimento e implementação co conceito "safe-by-design" permitindo soluções seguras em cuidados de saúde
ProSafe/0001/2016
Universidade de Coimbra Centro de Neurociências e Biologia Celular, Portugal
Fundação para a Ciência e a Tecnologia
Concluído
2015/03/01 - 2018/12/31 Roles and mechanisms of synuclein and ataxin-3 spreading in Parkinson and Machado-Joseph diseases
JPND-CD/0001/2013
Universidade de Coimbra Centro de Neurociências e Biologia Celular, Portugal
Fundação para a Ciência e a Tecnologia

Fundação para a Ciência e a Tecnologia
Concluído
2012/01/24 - 2015/07/30 Dissecting the pathogenesis of Machado-Joseph disease in a new human disease model derived from induced pluripotent stem cells
PTDC/SAU-NMC/116512/2010
Universidade de Coimbra Centro de Neurociências e Biologia Celular, Portugal
Fundação para a Ciência e a Tecnologia

Fundação para a Ciência e a Tecnologia, I.P.
Concluído
2011/04/01 - 2014/09/30 Cell to cell transport of alpha-synuclein in Parkinson´s Disease. The progression factor?
PTDC/SAU-NMC/109955/2009
Universidade de Coimbra Centro de Neurociências e Biologia Celular, Portugal
Fundação para a Ciência e a Tecnologia
Concluído
2010/04/01 - 2013/07/15 Caloric restriction increases lifespan: role of neuropeptide Y on autophagy
PTDC/SAU-FCF/099082/2008
Universidade de Coimbra Centro de Neurociências e Biologia Celular, Portugal
Fundação para a Ciência e a Tecnologia

Fundação para a Ciência e a Tecnologia
Concluído
2010/02/05 - 2013/04/30 The role of calpain-mediated proteolysis of ataxin-3 in Machado-Joseph disease: a molecular therapy approach with viral vectors
PTDC/SAU-NEU/099307/2008
Universidade de Coimbra Centro de Inovação em Biomedicina e Biotecnologia, Portugal
Fundação para a Ciência e a Tecnologia

Fundação para a Ciência e a Tecnologia, I.P.
Concluído
2011/01/01 - 2012/12/31 Strategic Project - LA 1 - 2011-2012
PEst-C/SAU/LA0001/2011
Universidade de Coimbra Centro de Neurociências e Biologia Celular, Portugal
Fundação para a Ciência e a Tecnologia
Concluído
2010/03/18 - 2012/02/29 Role of adenosine A2A receptors in microglia and glutamatergic synapses in the control of synaptic plasticity and brain damage
PTDC/SAU-NEU/108668/2008
Universidade de Coimbra Centro de Neurociências e Biologia Celular, Portugal
Fundação para a Ciência e a Tecnologia
Concluído
2005/09/01 - 2008/08/31 Lentiviral vectors for gene silencing in polyglutamine disorders: Ataxin-3 gene silencing by lentiviral vectors-mediated delivery of double-stranded RNAs
POCI/SAU-MMO/56055/2004
Universidade de Coimbra Centro de Inovação em Biomedicina e Biotecnologia, Portugal
Fundação para a Ciência e a Tecnologia

Fundação para a Ciência e a Tecnologia, I.P.
Concluído
1998/02/01 - 2001/03/31 SISTEMAS POLIMÉRICOS CONTENDO FACTORES NEUROTRÓFICOS PARA TERAPIA DE DOENÇA NEURODEGENERATIVA
PRAXIS XXI/BD/9469/96
Fundação para a Ciência e a Tecnologia
Concluído
Produções

Publicações

Artigo em conferência
  1. Coelho, Patricia; Fão, Lígia; Nobre, Rui Jorge; Pereira de Almeida, Luis ; Peça, João; Rego, Ana Cristina Carvalho. "Impact of SAPAP3 on mitochondrial function in Huntingtons disease". 2021.
    Publicado
  2. Lobo, Diana; Nobre, Rui Jorge; Miranda, Catarina; Pereira, Dina; Castelhano, João; Sereno, José; Castelo-Branco, Miguel; et al. "Blood-brain barrier dysfunction as a neuropathological feature in Machado-Joseph Disease: results from human and mouse samples". Trabalho apresentado em XVI Meeting of the Portuguese Society for Neuroscience (SPN2019), 2019.
    10.3389/conf.fncel.2019.01.00022
  3. Nobre, Rui; Saraiva, Joana; Paixão, Susana; Fusco, Cellia; Santana, Magda; Miranda, Catarina; Petrella, Lorena; et al. "Non-invasive and allele-specific silencing therapy for Polyglutamine disorders: the case of Machado-Joseph disease/Spinocerebellar ataxia type 3". Trabalho apresentado em XVI Meeting of the Portuguese Society for Neuroscience (SPN2019), 2019.
    Publicado • 10.3389/conf.fncel.2019.01.00007
Artigo em jornal
  1. Ramalho-Santos, João; Varela Amaral, Sara; Correia, Marta Quatorze; Cardoso, João; Pereira de Almeida, Luis; André Caetano; Ana Catarina Vinhas; et al. "Uma Viagem Rara", Público, 2020, https://www.publico.pt/2020/02/28/ciencia/fotogaleria/viagem-rara-400481.
Artigo em revista
  1. Mendonça, Liliana S.; Henriques, Daniel; Fernandes, Vanessa; Moreira, Ricardo; Brás, João; Duarte, Sónia; Schwamborn, Jens C.; de Almeida, Luís Pereira. "Graft-derived neurons and bystander effects are maintained for six months after human iPSC-derived NESC transplantation in mice’s cerebella". Scientific Reports 14 1 (2024): http://dx.doi.org/10.1038/s41598-024-53542-x.
    10.1038/s41598-024-53542-x
  2. Lopes-Nunes, Jéssica; Simões, Pedro; Moreira, David; Leandro, Kevin; Nobre, Rui Jorge; Pereira de Almeida, Luís; Campello, Maria Paula Cabral; et al. "RNA-based liposomes for oral cancer: From biophysical characterization to biological evaluation". International Journal of Biological Macromolecules 259 (2024): 129157. http://dx.doi.org/10.1016/j.ijbiomac.2023.129157.
    10.1016/j.ijbiomac.2023.129157
  3. Henriques, Carina; Lopes, Miguel M; Silva, Ana C; Lobo, Diana D; Aron Badin, Romina; Hantraye, Philippe; Pereira de Almeida, Luís; Nobre, Rui Jorge. "Viral-based animal models in polyglutamine disorders". Brain (2024): http://dx.doi.org/10.1093/brain/awae012.
    10.1093/brain/awae012
  4. Soares Martins, Tânia; Pelech, Steven; Ferreira, Maria; Pinho, Beatriz; Leandro, Kevin; de Almeida, Luís Pereira; Breitling, Benedict; et al. "Phosphoproteome Microarray Analysis of Extracellular Particles as a Tool to Explore Novel Biomarker Candidates for Alzheimer’s Disease". International Journal of Molecular Sciences 25 3 (2024): 1584. http://dx.doi.org/10.3390/ijms25031584.
    10.3390/ijms25031584
  5. Weber, Niklas; Buchholz, Maresa; Rädke, Anika; Faber, Jennifer; Schmitz-Hübsch, Tanja; Jacobi, Heike; Klockgether, Thomas; et al. "Factors Influencing Health-Related Quality of Life of Patients with Spinocerebellar Ataxia". The Cerebellum (2024): http://dx.doi.org/10.1007/s12311-024-01657-2.
    10.1007/s12311-024-01657-2
  6. Hengel, Holger; Martus, Peter; Faber, Jennifer; Giunti, Paola; Garcia-Moreno, Hector; Solanky, Nita; Klockgether, Thomas; et al. "Correction to: The frequency of non-motor symptoms in SCA3 and their association with disease severity and lifestyle factors". Journal of Neurology 271 1 (2023): 628-629. http://dx.doi.org/10.1007/s00415-023-12064-8.
    10.1007/s00415-023-12064-8
  7. Mariana Martins; Ana Rafaela Oliveira; Solange Martins; José Pedro Vieira; Pedro Perdigão; Ana Rita Fernandes; Luís Pereira de Almeida; et al. "A Novel Genetic Variant in MBD5 Associated with Severe Epilepsy and Intellectual Disability: Potential Implications on Neural Primary Cilia". International Journal of Molecular Sciences (2023): https://doi.org/10.3390/ijms241612603.
    10.3390/ijms241612603
  8. Patrícia Pereira; Ana S. Neto; Ana S. Rodrigues; Inês Barros; Catarina Miranda; João Ramalho-Santos; Luís Pereira de Almeida; et al. "In Vitro Evaluation of Biphasic Calcium Phosphate Scaffolds Derived from Cuttlefish Bone Coated with Poly(ester urea) for Bone Tissue Regeneration". Polymers (2023): https://doi.org/10.3390/polym15102256.
    10.3390/polym15102256
  9. Maria Soares; Maria M. Pinto; Rui Jorge Nobre; Luís Pereira de Almeida; Maria da Graça Rasteiro; Teresa Almeida-Santos; João Ramalho-Santos; Ana Paula Sousa. "Isolation of Extracellular Vesicles from Human Follicular Fluid: Size-Exclusion Chromatography versus Ultracentrifugation". Biomolecules (2023): https://doi.org/10.3390/biom13020278.
    10.3390/biom13020278
  10. Carmo-Silva, S.; Ferreira-Marques, M.; Nóbrega, C.; Botelho, M.; Costa, D.; Aveleira, C.A.; Pulst, S.M.; et al. "Ataxin-2 in the hypothalamus at the crossroads between metabolism and clock genes". Journal of Molecular Endocrinology 70 1 (2023): http://www.scopus.com/inward/record.url?eid=2-s2.0-85143645604&partnerID=MN8TOARS.
    Em revisão • 10.1530/JME-21-0272
  11. Klockgether, T.; Synofzik, M.; Alhusaini, S.; Anheim, M.; Antonijevic, I.; Ashizawa, T.; Bataller, L.; et al. "Consensus Recommendations for Clinical Outcome Assessments and Registry Development in Ataxias: Ataxia Global Initiative (AGI) Working Group Expert Guidance". Cerebellum (2023): http://www.scopus.com/inward/record.url?eid=2-s2.0-85151668891&partnerID=MN8TOARS.
    10.1007/s12311-023-01547-z
  12. Rufino-Ramos, D.; Albuquerque, P.R.; Leandro, K.; Carmona, V.; Martins, I.M.; Fernandes, R.; Henriques, C.; et al. "Extracellular vesicle-based delivery of silencing sequences for the treatment of Machado-Joseph disease/spinocerebellar ataxia type 3". Molecular Therapy 31 5 (2023): 1275-1292. http://www.scopus.com/inward/record.url?eid=2-s2.0-85154619372&partnerID=MN8TOARS.
    10.1016/j.ymthe.2023.04.001
  13. Uebachs, M.; Wegner, P.; Schaaf, S.; Kugai, S.; Jacobi, H.; Kuo, S.-H.; Ashizawa, T.; et al. "SCAview: an Intuitive Visual Approach to the Integrative Analysis of Clinical Data in Spinocerebellar Ataxias". Cerebellum (2023): http://www.scopus.com/inward/record.url?eid=2-s2.0-85151467845&partnerID=MN8TOARS.
    10.1007/s12311-023-01546-0
  14. Santana, M.M.; Gaspar, L.S.; Pinto, M.M.; Silva, P.; Adão, D.; Pereira, D.; Ribeiro, J.A.; et al. "A standardised protocol for blood and cerebrospinal fluid collection and processing for biomarker research in ataxia". Neuropathology and Applied Neurobiology 49 2 (2023): http://www.scopus.com/inward/record.url?eid=2-s2.0-85153765323&partnerID=MN8TOARS.
    10.1111/nan.12892
  15. Ferreira-Marques, M.; Carvalho, A.; Franco, A.C.; Leal, A.; Botelho, M.; Carmo-Silva, S.; Águas, R.; et al. "Ghrelin delays premature aging in Hutchinson-Gilford progeria syndrome". Aging Cell (2023): http://www.scopus.com/inward/record.url?eid=2-s2.0-85174420928&partnerID=MN8TOARS.
    10.1111/acel.13983
  16. Raposo, M.; Hübener-Schmid, J.; Ferreira, A.F.; Vieira Melo, A.R.; Vasconcelos, J.; Pires, P.; Kay, T.; et al. "Blood transcriptome sequencing identifies biomarkers able to track disease stages in spinocerebellar ataxia type 3". Brain 146 10 (2023): 4132-4143. http://www.scopus.com/inward/record.url?eid=2-s2.0-85173781207&partnerID=MN8TOARS.
    10.1093/brain/awad128
  17. Koppenol, R.; Conceição, A.; Afonso, I.T.; Afonso-Reis, R.; Costa, R.G.; Tomé, S.; Teixeira, D.; et al. "The stress granule protein G3BP1 alleviates spinocerebellar ataxia-associated deficits". Brain 146 6 (2023): 2346-2363. http://www.scopus.com/inward/record.url?eid=2-s2.0-85160404450&partnerID=MN8TOARS.
    10.1093/brain/awac473
  18. Arnaut, Z.A.; Pinto, S.M.A.; Aroso, R.T.; Amorim, A.S.; Lobo, C.S.; Schaberle, F.A.; Pereira, D.; et al. "Selective, broad-spectrum antiviral photodynamic disinfection with dicationic imidazolyl chlorin photosensitizers". Photochemical and Photobiological Sciences (2023): http://www.scopus.com/inward/record.url?eid=2-s2.0-85172998540&partnerID=MN8TOARS.
    10.1007/s43630-023-00476-4
  19. Hengel, H.; Martus, P.; Faber, J.; Giunit, P.; Garcia-Moreno, H.; Solanky, N.; Klockgether, T.; et al. "The frequency of non-motor symptoms in SCA3 and their association with disease severity and lifestyle factors". Journal of Neurology 270 2 (2023): 944-952. http://www.scopus.com/inward/record.url?eid=2-s2.0-85141199384&partnerID=MN8TOARS.
    10.1007/s00415-022-11441-z
  20. Rufino-Ramos, David; Leandro, K; Perdigão, Pedro; O'Brien, K; Pinto, MM; Santana, MM; van Solinge, TS; et al. "Extracellular communication between brain cells through functional transfer of Cre mRNA". Molecular Therapy (2023): http://www.scopus.com/inward/record.url?eid=2-s2.0-85160280091&partnerID=MN8TOARS.
    No prelo • 10.1016/j.ymthe.2023.05.012
  21. Miguel M. Lopes; Jacques Paysan; José Rino; Sara M. Lopes; Luís Pereira de Almeida; Luísa Cortes; Rui Jorge Nobre. "A new protocol for whole-brain biodistribution analysis of AAVs by tissue clearing, light-sheet microscopy and semi-automated spatial quantification". Gene Therapy (2022): https://doi.org/10.1038/s41434-022-00372-z.
    10.1038/s41434-022-00372-z
  22. Rodrigo F. N. Ribeiro; Dina Pereira; Luis Pereira de Almeida; Maria Manuel C. Silva; Cláudia Cavadas. "SIRT1 activation and its circadian clock control: a promising approach against (frailty in) neurodegenerative disorders". Aging Clinical and Experimental Research (2022): https://doi.org/10.1007/s40520-022-02257-y.
    10.1007/s40520-022-02257-y
  23. Roderick P.P.W.M. Maas; Steven Teerenstra; Manuela Lima; Paula Pires; Luís Pereira de Almeida; Judith van Gaalen; Dagmar Timmann; et al. "Differential Temporal Dynamics of Axial and Appendicular Ataxia in SCA3". Movement Disorders (2022): https://doi.org/10.1002/mds.29135.
    10.1002/mds.29135
  24. Hector Garcia-Moreno; Mercedes Prudencio; Gilbert Thomas-Black; Nita Solanky; Karen R. Jansen-West; Rana Hanna AL-Shaikh; Amanda Heslegrave; et al. "Tau and neurofilament light-chain as fluid biomarkers in spinocerebellar ataxia type 3". European Journal of Neurology (2022): https://doi.org/10.1111/ene.15373.
    10.1111/ene.15373
  25. Helena Leal; João Cardoso; Patrícia Valério; Marta Quatorze; Vítor Carmona; Janete Cunha-Santos; Luís Pereira de Almeida; et al. "SIRT2 Deficiency Exacerbates Hepatic Steatosis via a Putative Role of the ER Stress Pathway". International Journal of Molecular Sciences 23 12 (2022): 6790-6790. https://doi.org/10.3390/ijms23126790.
    10.3390/ijms23126790
  26. Koen Breyne; Stefano Ughetto; David Rufino-Ramos; Shadi Mahjoum; Emily A. Grandell; Luís P. de Almeida; Xandra O. Breakefield. "Exogenous loading of extracellular vesicles, virus-like particles, and lentiviral vectors with supercharged proteins". Communications Biology (2022): https://doi.org/10.1038/s42003-022-03440-7.
    10.1038/s42003-022-03440-7
  27. Ana Vasconcelos-Ferreira; Sara Carmo-Silva; José Miguel Codêsso; Patrick Silva; Alberto Rolim Muro Martinez; Marcondes Cavalcante França Jr; Clévio Nóbrega; et al. "The autophagy-enhancing drug carbamazepine improves neuropathology and motor impairment in mouse models of Machado–Joseph disease". Neuropathology and Applied Neurobiology (2022): https://doi.org/10.1111/nan.12763.
    10.1111/nan.12763
  28. Holger Hengel; Peter Martus; Jennifer Faber; Hector Garcia-Moreno; Nita Solanky; Paola Giunti; Thomas Klockgether; et al. "Characterization of Lifestyle in Spinocerebellar Ataxia Type 3 and Association with Disease Severity". Movement Disorders (2022): https://doi.org/10.1002/mds.28844.
    10.1002/mds.28844
  29. Ana Teresa Simões; Vítor Carmona; Joana Duarte-Neves; Janete Cunha-Santos; Luís Pereira de Almeida. "Identification of the calpain-generated toxic fragment of ataxin-3 protein provides new avenues for therapy of Machado–Joseph disease| Spinocerebellar ataxia type 3". Neuropathology and Applied Neurobiology (2022): https://doi.org/10.1111/nan.12748.
    10.1111/nan.12748
  30. Vasconcelos-Ferreira, A.; Martins, I.M.; Lobo, D.; Pereira, D.; Lopes, M.M.; Faro, R.; Lopes, S.M.; et al. "ULK overexpression mitigates motor deficits and neuropathology in mouse models of Machado-Joseph disease". Molecular Therapy 30 1 (2022): 370-387. http://www.scopus.com/inward/record.url?eid=2-s2.0-85115030983&partnerID=MN8TOARS.
    10.1016/j.ymthe.2021.07.012
  31. Rufino-Ramos, D.; Lule, S.; Mahjoum, S.; Ughetto, S.; Cristopher Bragg, D.; Pereira de Almeida, L.; Breakefield, X.O.; Breyne, K.. "Using genetically modified extracellular vesicles as a non-invasive strategy to evaluate brain-specific cargo". Biomaterials 281 (2022): http://www.scopus.com/inward/record.url?eid=2-s2.0-85122652441&partnerID=MN8TOARS.
    10.1016/j.biomaterials.2022.121366
  32. Nobre, R.J.; Lobo, D.D.; Henriques, C.; Duarte, S.P.; Lopes, S.M.; Silva, A.C.; Lopes, M.M.; et al. "MiRNA-Mediated Knockdown of ATXN3 Alleviates Molecular Disease Hallmarks in a Mouse Model for Spinocerebellar Ataxia Type 3". Nucleic Acid Therapeutics 32 3 (2022): 194-205. http://www.scopus.com/inward/record.url?eid=2-s2.0-85129129262&partnerID=MN8TOARS.
    10.1089/nat.2021.0020
  33. Miranda, C.O.; Nobre, R.J.; Paiva, V.H.; Duarte, J.V.; Castelhano, J.; Petrella, L.I.; Sereno, J.; et al. "Cerebellar morphometric and spectroscopic biomarkers for Machado-Joseph Disease". Acta Neuropathologica Communications 10 1 (2022): http://www.scopus.com/inward/record.url?eid=2-s2.0-85126741777&partnerID=MN8TOARS.
    10.1186/s40478-022-01329-4
  34. Lobo, C.S.; Rodrigues-Santos, P.; Pereira, D.; Núñez, J.; Trêpa, J.C.D.; Sousa, D.L.; Lourenço, J.V.; et al. "Photodynamic disinfection of SARS-CoV-2 clinical samples using a methylene blue formulation". Photochemical and Photobiological Sciences (2022): http://www.scopus.com/inward/record.url?eid=2-s2.0-85126514875&partnerID=MN8TOARS.
    10.1007/s43630-022-00202-6
  35. Almeida, S.F.F.; Fonseca, A.; Sereno, J.; Ferreira, H.R.S.; Lapo-Pais, M.; Martins-Marques, T.; Rodrigues, T.; et al. "Osteosarcoma-Derived Exosomes as Potential PET Imaging Nanocarriers for Lung Metastasis". Small 18 49 (2022): http://www.scopus.com/inward/record.url?eid=2-s2.0-85141363010&partnerID=MN8TOARS.
    10.1002/smll.202203999
  36. Brás, J.; Henriques, D.; Moreira, R.; Santana, M.M.; Silva-Pedrosa, R.; Adão, D.; Braz, S.; et al. "Establishment and characterization of human pluripotent stem cells-derived brain organoids to model cerebellar diseases". Scientific Reports 12 1 (2022): http://www.scopus.com/inward/record.url?eid=2-s2.0-85134499812&partnerID=MN8TOARS.
    10.1038/s41598-022-16369-y
  37. Quintino, L.; Almeida, L.P.D.; Lundberg, C.. "Editorial: Gene therapy 2.0: Biotechnology for circuit engineering and complex therapeutic approaches". Frontiers in Bioengineering and Biotechnology 10 (2022): http://www.scopus.com/inward/record.url?eid=2-s2.0-85143363515&partnerID=MN8TOARS.
    10.3389/fbioe.2022.1082883
  38. Carmo-Silva, Sara; Ferreira-Marques, Marisa; Nóbrega, Clévio David Rodrigues ; Botelho, Mariana; Costa, Daniela G.; Pulst, Stefan M; Pereira de Almeida, Luis Fernando Morgado; Cavadas, Claudia. "Deciphering a new role for Ataxin-2 in the hypothalamus: linking metabolism and circadian rhythm regulation.". Molecular Endocrinology (2022):
    Em revisão
  39. Ana S. Neto; Patrícia Pereira; Ana C. Fonseca; Carla Dias; Mariana C. Almeida; Inês Barros; Catarina O. Miranda; et al. "Highly Porous Composite Scaffolds Endowed with Antibacterial Activity for Multifunctional Grafts in Bone Repair". Polymers (2021): https://doi.org/10.3390/polym13244378.
    10.3390/polym13244378
  40. Shadi Mahjoum; David Rufino-Ramos; Luís Pereira de Almeida; Marike L. D. Broekman; Xandra O. Breakefield; Thomas S. van Solinge; Mahjoum, Shadi; et al. "Living Proof of Activity of Extracellular Vesicles in the Central Nervous System". International Journal of Molecular Sciences 22 14 (2021): 7294-7294. https://doi.org/10.3390/ijms22147294.
    10.3390/ijms22147294
  41. Barros, I.; Silva, A.; de Almeida, L.P.; Miranda, C.O.. "Mesenchymal stromal cells to fight SARS-CoV-2: Taking advantage of a pleiotropic therapy". Cytokine and Growth Factor Reviews (2021): http://www.scopus.com/inward/record.url?eid=2-s2.0-85098642605&partnerID=MN8TOARS.
    10.1016/j.cytogfr.2020.12.002
  42. Duarte-Neves, J.; Cavadas, C.; Pereira de Almeida, L.. "Neuropeptide Y (NPY) intranasal delivery alleviates Machado–Joseph disease". Scientific Reports 11 1 (2021): http://www.scopus.com/inward/record.url?eid=2-s2.0-85100703911&partnerID=MN8TOARS.
    10.1038/s41598-021-82339-5
  43. Klionsky, D.J.; Abdel-Aziz, A.K.; Abdelfatah, S.; Abdellatif, M.; Abdoli, A.; Abel, S.; Abeliovich, H.; et al. "Guidelines for the use and interpretation of assays for monitoring autophagy (4th edition)". Autophagy (2021): http://www.scopus.com/inward/record.url?eid=2-s2.0-85102619204&partnerID=MN8TOARS.
    10.1080/15548627.2020.1797280
  44. Hübener-Schmid, J.; Kuhlbrodt, K.; Peladan, J.; Faber, J.; Santana, M.M.; Hengel, H.; Jacobi, H.; et al. "Polyglutamine-Expanded Ataxin-3: A Target Engagement Marker for Spinocerebellar Ataxia Type 3 in Peripheral Blood". Movement Disorders (2021): http://www.scopus.com/inward/record.url?eid=2-s2.0-85113149446&partnerID=MN8TOARS.
    10.1002/mds.28749
  45. Marcelo, A.; Afonso, I.T.; Afonso-Reis, R.; Brito, D.V.C.; Costa, R.G.; Rosa, A.; Alves-Cruzeiro, J.; et al. "Autophagy in Spinocerebellar ataxia type 2, a dysregulated pathway, and a target for therapy". Cell Death and Disease 12 12 (2021): 8-28. http://www.scopus.com/inward/record.url?eid=2-s2.0-85120082938&partnerID=MN8TOARS.
    10.1038/s41419-021-04404-1
  46. Walter, J.; Bolognin, S.; Poovathingal, S.K.; Magni, S.; Gérard, D.; Antony, P.M.A.; Nickels, S.L.; et al. "The Parkinson's-disease-associated mutation LRRK2-G2019S alters dopaminergic differentiation dynamics via NR2F1". Cell Reports 37 3 (2021): http://www.scopus.com/inward/record.url?eid=2-s2.0-85117275453&partnerID=MN8TOARS.
    10.1016/j.celrep.2021.109864
  47. Aguiar, S.I.; Dias, J.N.R.; André, A.S.; Silva, M.L.; Martins, D.; Carrapiço, B.; Castanho, M.; et al. "Highly specific blood-brain barrier transmigrating single-domain antibodies selected by an in vivo phage display screening". Pharmaceutics 13 10 (2021): http://www.scopus.com/inward/record.url?eid=2-s2.0-85116780736&partnerID=MN8TOARS.
    10.3390/pharmaceutics13101598
  48. Moreira, R.; Mendonça, L.S.; de Almeida, L.P.. "Extracellular vesicles physiological role and the particular case of disease-spreading mechanisms in polyglutamine diseases". International Journal of Molecular Sciences 22 22 (2021): http://www.scopus.com/inward/record.url?eid=2-s2.0-85118955937&partnerID=MN8TOARS.
    10.3390/ijms222212288
  49. Marcelo, A.; Koppenol, R.; de Almeida, L.P.; Matos, C.A.; Nóbrega, C.. "Stress granules, RNA-binding proteins and polyglutamine diseases: too much aggregation?". Cell Death and Disease 12 6 (2021): http://www.scopus.com/inward/record.url?eid=2-s2.0-85107594482&partnerID=MN8TOARS.
    10.1038/s41419-021-03873-8
  50. Diana Duarte Lobo; Rui Jorge Nobre; Catarina Oliveira Miranda; Dina Pereira; João Castelhano; José Sereno; Arnulf Koeppen; Miguel Castelo-Branco; Luís Pereira de Almeida. "The blood-brain barrier is disrupted in Machado-Joseph disease/spinocerebellar ataxia type 3: evidence from transgenic mice and human post-mortem samples". Acta Neuropathologica Communications (2020): https://doi.org/10.1186/s40478-020-00955-0.
    10.1186/s40478-020-00955-0
  51. Laetitia S. Gaspar; Magda M. Santana; Carina Henriques; Maria M. Pinto; Teresa M. Ribeiro-Rodrigues; Henrique Girão; Rui Jorge Nobre; Luís Pereira de Almeida. "Simple and Fast SEC-Based Protocol to Isolate Human Plasma-Derived Extracellular Vesicles for Transcriptional Research". Molecular Therapy - Methods & Clinical Development (2020): https://doi.org/10.1016/j.omtm.2020.07.012.
    10.1016/j.omtm.2020.07.012
  52. Santana, Magda M.; Paixão, Susana; Cunha-Santos, Janete; Silva, Teresa Pereira; Trevino-Garcia, Allyson; Gaspar, Laetitia S.; Nóbrega, Clévio; et al. "Trehalose alleviates the phenotype of Machado–Joseph disease mouse models". Journal of Translational Medicine 18 1 (2020): http://dx.doi.org/10.1186/s12967-020-02302-2.
    10.1186/s12967-020-02302-2
  53. Lopes, Sara Monteiro; Faro, Rosário; Lopes, Miguel Monteiro; Onofre, Isabel; Mendonça, Nuno; Ribeiro, Joana; Januário, Cristina; Nobre, Rui Jorge; Pereira de Almeida, Luís. "Protocol for the Characterization of the CAG Tract and Flanking Polymorphisms in Machado-Joseph Disease: Impact on Diagnosis and Development of Gene-Based Therapies". The Journal of Molecular Diagnostics (2020): http://dx.doi.org/10.1016/j.jmoldx.2020.03.003.
    10.1016/j.jmoldx.2020.03.003
  54. Barros-Viegas, Ana Teresa; Carmona, Vítor; Ferreiro, Elisabete; Guedes, Joana; Cardoso, Ana Maria; Cunha, Pedro; Pereira de Almeida, Luís; et al. "miRNA-31 Improves Cognition and Abolishes Amyloid-ß Pathology by Targeting APP and BACE1 in an Animal Model of Alzheimer’s Disease". Molecular Therapy - Nucleic Acids 19 (2020): 1219-1236. http://dx.doi.org/10.1016/j.omtn.2020.01.010.
    10.1016/j.omtn.2020.01.010
  55. Aveleira, Célia A; Ferreira-Marques, Marisa; Cortes, Luísa; Valero, Jorge; Pereira, Dina; Pereira de Almeida, Luís; Cavadas, Cláudia. "Neuropeptide Y Enhances Progerin Clearance and Ameliorates the Senescent Phenotype of Human Hutchinson-Gilford Progeria Syndrome Cells". The Journals of Gerontology: Series A (2020): http://dx.doi.org/10.1093/gerona/glz280.
    10.1093/gerona/glz280
  56. Wilke, C.; Haas, E.; Reetz, K.; Faber, J.; Garcia-Moreno, H.; Santana, M.M.; van de Warrenburg, B.; et al. "Neurofilaments in spinocerebellar ataxia type 3: blood biomarkers at the preataxic and ataxic stage in humans and mice". EMBO Molecular Medicine 12 7 (2020): http://www.scopus.com/inward/record.url?eid=2-s2.0-85086096828&partnerID=MN8TOARS.
    10.15252/emmm.201911803
  57. Barros, I.; Marcelo, A.; Silva, T.P.; Barata, J.; Rufino-Ramos, D.; Pereira de Almeida, L.; Miranda, C.O.. "Mesenchymal Stromal Cells’ Therapy for Polyglutamine Disorders: Where Do We Stand and Where Should We Go?". Frontiers in Cellular Neuroscience 14 (2020): http://www.scopus.com/inward/record.url?eid=2-s2.0-85093862610&partnerID=MN8TOARS.
    10.3389/fncel.2020.584277
  58. Lopes, C.; Tang, Y.; Anjo, S.I.; Manadas, B.; Onofre, I.; de Almeida, L.P.; Daley, G.Q.; Schlaeger, T.M.; Rego, A.C.C.. "Mitochondrial and Redox Modifications in Huntington Disease Induced Pluripotent Stem Cells Rescued by CRISPR/Cas9 CAGs Targeting". Frontiers in Cell and Developmental Biology 8 (2020): http://www.scopus.com/inward/record.url?eid=2-s2.0-85092059116&partnerID=MN8TOARS.
    10.3389/fcell.2020.576592
  59. Gaspar, Laetitia S; Magda M Santana; Carina Henriques; Pinto, Maria Manuel ; Teresa M Ribeiro Rodrigues; Girao, Henrique; Rui Jorge Nobre; Pereira de Almeida, Luis. "Simple and Fast Size Exclusion Chromatography-based Protocol to Isolate Human Plasma-derived Extracellular Vesicles for Transcriptional Research". Molecular Therapy - Methods & Clinical Development (2020): http://dx.doi.org/10.1016/j.omtm.2020.07.012. 10.1016/j.omtm.2020.07.012.
    Publicado
  60. Henriques, Daniel; Moreira, Ricardo; Schwamborn, Jens; Pereira de Almeida, Luís; Mendonça, Liliana S.. "Successes and Hurdles in Stem Cells Application and Production for Brain Transplantation". Frontiers in Neuroscience 13 (2019): http://dx.doi.org/10.3389/fnins.2019.01194.
    10.3389/fnins.2019.01194
  61. Ana C Silva; Diana D Lobo; Inês M Martins; Sara M Lopes; Carina Henriques; Sónia P Duarte; Jean-Cosme Dodart; Rui Jorge Nobre; Luis Pereira de Almeida. "Antisense oligonucleotide therapeutics in neurodegenerative diseases: the case of polyglutamine disorders". Brain (2019): https://doi.org/10.1093/brain/awz328.
    10.1093/brain/awz328
  62. Liliana S Mendonça; Clévio Nóbrega; Silvia Tavino; Maximilian Brinkhaus; Carlos Matos; Sandra Tomé; Ricardo Moreira; et al. "Ibuprofen enhances synaptic function and neural progenitors proliferation markers and improves neuropathology and motor coordination in Machado-Joseph disease models". Human Molecular Genetics (2019): https://doi.org/10.1093/hmg/ddz097.
    10.1093/hmg/ddz097
  63. Almeida, Luis. "Neural Stem Cells of Parkinson's Disease Patients Exhibit Aberrant Mitochondrial Morphology and Functionality.". Stem cell reports (2019): http://europepmc.org/articles/PMC6522948.
    10.1016/j.stemcr.2019.03.004
  64. Nóbrega, Clévio; Codesso, Jose Miguel; Mendonca, Liliana; de Almeida, Luis Pereira. "RNA interference therapy for Machado-Joseph disease: Long-term safety profile of lentiviral vectors encoding short hairpin RNAs targeting mutant ataxin-3". (2019): http://hdl.handle.net/10400.1/14340.
    10.1089/hum.2018.157
  65. Marcelo, Adriana; Brito, Filipa; Carmo-Silva, Sara; Matos, Carlos A.; Alves-Cruzeiro, Joao; Vasconcelos-Ferreira, Ana; Koppenol, Rebekah; et al. "Cordycepin activates autophagy through AMPK phosphorylation to reduce abnormalities in Machado-Joseph disease models". Human molecular genetics 28 1 (2019): 51-63. http://hdl.handle.net/10400.1/14482.
    10.1093/hmg/ddy328
  66. Nóbrega, Clévio; Mendonca, Liliana; Marcelo, Adriana; Lamaziere, Antonin; Tome, Sandra; Despres, Gaetan; Matos, Carlos A; et al. "Restoring brain cholesterol turnover improves autophagy and has therapeutic potential in mouse models of spinocerebellar ataxia". Acta Neuropathologica (2019): http://hdl.handle.net/10400.1/14197.
    10.1007/s00401-019-02019-7
  67. Rodrigues, C.F.D.; Serrano, E.; Patrício, M.I.; Val, M.M.; Albuquerque, P.; Fonseca, J.; Gomes, C.M.F.; et al. "Stroma-derived IL-6, G-CSF and Activin-A mediated dedifferentiation of lung carcinoma cells into cancer stem cells". Scientific Reports 8 1 (2018): http://www.scopus.com/inward/record.url?eid=2-s2.0-85050990420&partnerID=MN8TOARS.
    10.1038/s41598-018-29947-w
  68. Marques, A.P.; Cunha-Santos, J.; Leal, H.; Sousa-Ferreira, L.; Pereira de Almeida, L.; Cavadas, C.; Rosmaninho-Salgado, J.. "Dipeptidyl peptidase IV (DPP-IV) inhibition prevents fibrosis in adipose tissue of obese mice". Biochimica et Biophysica Acta - General Subjects 1862 3 (2018): 403-413. http://www.scopus.com/inward/record.url?eid=2-s2.0-85037668547&partnerID=MN8TOARS.
    10.1016/j.bbagen.2017.11.012
  69. Pólvora-Brandão, D.; Joaquim, M.; Godinho, I.; Aprile, D.; Álvaro, A.R.; Onofre, I.; Raposo, A.C.; et al. "Loss of hierarchical imprinting regulation at the Prader-Willi/Angelman syndrome locus in human iPSCs". Human molecular genetics 27 23 (2018): 3999-4011. http://www.scopus.com/inward/record.url?eid=2-s2.0-85056694837&partnerID=MN8TOARS.
    10.1093/hmg/ddy274
  70. Oliveira Miranda, C.; Marcelo, A.; Silva, T.P.; Barata, J.; Vasconcelos-Ferreira, A.; Pereira, D.; Nóbrega, C.; et al. "Repeated Mesenchymal Stromal Cell Treatment Sustainably Alleviates Machado-Joseph Disease". Molecular Therapy (2018): http://www.scopus.com/inward/record.url?eid=2-s2.0-85050950218&partnerID=MN8TOARS.
    10.1016/j.ymthe.2018.07.007
  71. Gonçalves, N.; Simões, A.T.; Prediger, R.D.; Hirai, H.; Cunha, R.A.; Pereira de Almeida, L.. "Caffeine alleviates progressive motor deficits in a transgenic mouse model of spinocerebellar ataxia". Annals of Neurology 81 3 (2017): 407-418. http://www.scopus.com/inward/record.url?eid=2-s2.0-85013441188&partnerID=MN8TOARS.
    10.1002/ana.24867
  72. Rufino-Ramos, D.; Albuquerque, P.R.; Carmona, V.; Perfeito, R.; Nobre, R.J.; Pereira de Almeida, L.. "Extracellular vesicles: Novel promising delivery systems for therapy of brain diseases". Journal of Controlled Release 262 (2017): 247-258. http://www.scopus.com/inward/record.url?eid=2-s2.0-85026758579&partnerID=MN8TOARS.
    10.1016/j.jconrel.2017.07.001
  73. Cristo, F.; Inácio, J.M.; Rosas, G.; Carreira, I.M.; Melo, J.B.; de Almeida, L.P.; Mendes, P.; et al. "Generation of human iPSC line from a patient with laterality defects and associated congenital heart anomalies carrying a DAND5 missense alteration". Stem Cell Research 25 (2017): 152-156. http://www.scopus.com/inward/record.url?eid=2-s2.0-85033403571&partnerID=MN8TOARS.
    10.1016/j.scr.2017.10.019
  74. Hachigian, L.J.; Carmona, V.; Fenster, R.J.; Kulicke, R.; Heilbut, A.; Sittler, A.; Pereira de Almeida, L.; et al. "Control of Huntington's Disease-Associated Phenotypes by the Striatum-Enriched Transcription Factor Foxp2". Cell Reports 21 10 (2017): 2688-2695. http://www.scopus.com/inward/record.url?eid=2-s2.0-85038085324&partnerID=MN8TOARS.
    10.1016/j.celrep.2017.11.018
  75. Matos, C.A.; de Almeida, L.P.; Nóbrega, C.. "Proteolytic cleavage of polyglutamine disease-causing proteins: Revisiting the toxic fragment hypothesis". Current Pharmaceutical Design 23 5 (2017): 753-775. http://www.scopus.com/inward/record.url?eid=2-s2.0-85017122161&partnerID=MN8TOARS.
    10.2174/1381612822666161227121912
Capítulo de livro
  1. Ribeiro, Sandra Macedo-; Almeida, Luís Pereira de; Carvalho, Ana Luísa; Rego, Ana Cristina. "Polyglutamine Expansion Diseases – the Case of Machado-Joseph Disease". In Interaction Between Neurons and Glia in Aging and Disease, 391-426. Boston, MA: Springer US, 2007.
    Publicado • 10.1007/978-0-387-70830-0_18
Livro
  1. Nóbrega, C.; Simões, A.T.; Duarte-Neves, J.; Duarte, S.; Vasconcelos-Ferreira, A.; Cunha-Santos, J.; Pereira, D.; et al. Molecular Mechanisms and Cellular Pathways Implicated in Machado-Joseph Disease Pathogenesis. 2018.
    10.1007/978-3-319-71779-1_18
  2. Matos, C.A.; Carmona, V.; Vijayakumar, U.-G.; Lopes, S.; Albuquerque, P.; Conceição, M.; Nobre, R.J.; Nóbrega, C.; de Almeida, L.P.. Gene therapies for polyglutamine diseases. 2018.
    10.1007/978-3-319-71779-1_20
  3. Mendonça, L.S.; Onofre, I.; Miranda, C.O.; Perfeito, R.; Nóbrega, C.; de Almeida, L.P.. Stem Cell-Based Therapies for Polyglutamine Diseases. 2018.
    10.1007/978-3-319-71779-1_21
Poster em conferência
  1. Ferreira-Marques, Marisa; André Carvalho; Ana Catarina Franco; Ana Leal; Botelho, Mariana; Carmo-Silva, Sara; Águas, Rodolfo; et al. Autor correspondente: Aveleira, Célia. "Ghrelin delays premature and accelerated aging phenotype in progeria experimental models". Trabalho apresentado em Pharma PhD Day ¿ Annual meeting of PhD students in Pharmaceutical Sciences, 2023.
  2. Silva, Ana Carolina; Henriques, Carina; Lobo, Diana Duarte; Pereira, Dina; Duarte, Sónia; Lopes, Sara Monteiro; Lopes, Miguel Monteiro; et al. "Investigating routes of administration and AAV serotypes for development of a gene-based therapy for spinocerebellar ataxia type 3 (SCA3)". Trabalho apresentado em ESGCT 30th Congress, 2023.
  3. Silva, Ana Carolina; Henriques, Carina; Lobo, Diana Duarte; Fernandes, Ana Rita; Lopes, Miguel Monteiro; Pereira, Dina; Duarte, Sónia; et al. "Allele-specific silencing of mutant ATXN3 rescues motor deficits and neuropathology in a severely impaired mouse model of spinocerebellar ataxia type 3 (SCA3) upon intra-cisterna magna administration". Trabalho apresentado em ESGCT 30th Congress, 2023.
  4. Lobo, Diana Duarte; Quintino, Luis; Silva, Ana Carolina; Henriques, Carina; Ribeiro, Rodrigo; Lopes, Sara Monteiro; Perdigão, Pedro; et al. "CRISPR activation as a therapeutic tool for Spinocerebellar ataxia type 3 (SCA3)". Trabalho apresentado em ESGCT 30th Congress, 2023.
  5. Leandro, Kevin; Rufino-Ramos, David; Lopes, Sara Monteiro; Pasqua, C; Santos P; Silva, Ana Carolina; Lobo, Diana Duarte; et al. "Extracellular vesicles-mediated delivery of CRISPR/Cas9 systems to treat Spinocerebellar Ataxia Type 3/Machado-Joseph Disease". Trabalho apresentado em CAG Triplet Repeat Disorders GRC, 2023.
  6. Marcelo, Adriana; Afonso, Inês T.; Rajado, Ana Teresa; Rafael G. Costa; Afonso-Reis, Ricardo; Pereira de Almeida, Luis ; Nóbrega, Clévio David Rodrigues . Autor correspondente: Nóbrega, Clévio David Rodrigues. "Tackling Machado-Joseph disease through stress granules: is protein CARHSP1 a potential target for therapeutics?". Trabalho apresentado em FENS Regional Meeting 2023, 2023.
  7. Marcelo, Adriana; Afonso, Inês T.; Rajado, Ana Teresa; Rafael G. Costa; Afonso-Reis, Ricardo; Pereira de Almeida, Luis ; Nóbrega, Clévio David Rodrigues . Autor correspondente: Nóbrega, Clévio David Rodrigues. "Stress granule protein CARHSP1 as a potential therapeutic strategy for MJD". Trabalho apresentado em ENCODS 2023, 2023.
  8. Ribeiro, Rodrigo; Pereira, Dina; Reis, Tiago; Lopes, Sara; Ferreira-Marques, Marisa; Fernandes, Rita; Gaspar, Laetitia S; et al. "The Circadian Clock is Disrupted in the YAC Machado-Joseph Disease Mouse Model". Trabalho apresentado em BEB Day 2023 - Doctoral Programme in Experimental Biology and Biomedicine (PDBEB) 17th symposium, 2023.
  9. Koppenol, Rebekah; Matos, Carlos A; Afonso-Reis, Ricardo; Pereira de Almeida, Luis ; Nóbrega, Clévio David Rodrigues. "Tackling spinocerebellar ataxia type 2: targeting the ATXN2 gene with CRISPR-Cas-based silencing strategies". Trabalho apresentado em FENS Regional Meeting 2023 (FRM 2023), 2023.
  10. Martins, Mariana; Oliveira, Ana Rafaela; Cammarata, Giuseppe; Martins, Solange; Pedro Perdigão; Guedes, Joana; Cardoso, Ana Luísa; et al. "BrainCils: Exploring the missing link between neuronal primary cilia dysfunction and neurodevelopmental disorders: hints from dental stem cell-derived brain organoids". Trabalho apresentado em Synapse Meeting, 2022.
  11. Perdigão, P; Matos, Carlos A; Lopes, Sara; Fernandes, Ana Rita; Lopes, Miguel; Conceição, André; Faro, Rosario; et al. "Modelling Machado-Joseph Disease in patient-derived isogenic lines by CRISPR/Cas9-mediated correction of ATXN3-CAG expansion". Trabalho apresentado em ESGCT 29th Annual Congress, European Society of Gene and Cell Therapy, Edinburgh, 2022, 2022.
  12. Silva, Ana Carolina; Lobo, Diana Duarte; Henriques, Carina; Martins, Maria Inês; Lopes, Sara Monteiro; Duarte, Sónia; Wagner, E; Nobre, Rui Jorge; Pereira de Almeida, Luis Fernando Morgado. "1st Symposium on Oligonucleotide Technologies and Therapeutics@Portugal". Trabalho apresentado em ESGCT 29th Congress, 2022.
  13. David Rufino-Ramos; Leandro, Kevin; Albuquerque, Patrícia Rosado; Carmona, Vitor; Martins, Ines Morgado; Faro, Rosário; Henriques, Carina; et al. "Extracellular vesicles-based delivery of silencing seqeunces for the treatment of Machado-Joseph disease (MJD)/ Spinocerebellar Ataxia type-3 (SCA3)". Trabalho apresentado em ESGCT 29th Congress, 2022.
  14. Henriques, Carina; Lopes, Miguel Monteiro; Albuquerque, Patrícia Rosado; Rufino-Ramos, David; Gaspar, Laetitia S; Duarte, Diana Lobo; Silva, Ana Carolina; et al. "Production and isolation of natural and biologically active exo-AAVs for brain gene delivery". Trabalho apresentado em . ESGCT 29th Congress, 2022.
  15. Henriques, Daniel; Moreira, Ricardo; Pedro Perdigão; Agnete Kirkeby; Pereira de Almeida, Luis ; Mendonça, Liliana S. "Generation and characterization of cerebellar neuronal progenitors for Machado-Joseph Disease treatment". Trabalho apresentado em The 29th Annual Meeting of the European Society of Gene & Cell Therapy ¿ ESGCT 2022, 2022.
  16. Moreira, Ricardo; Henriques, Daniel; Nóbrega, Clévio; Pereira de Almeida, Luis ; Liliana Mendonça. "Modulation of migration and neuronal differentiation of iPSC-derived Neuroepithelial Stem Cells to improve cell therapy in Machado-Joseph Disease". Trabalho apresentado em The 29th Annual Meeting of the European Society of Gene & Cell Therapy ¿ ESGCT 2022, 2022.
  17. Conceição, André; Koppenol, Rebekah; Marcelo, Adriana; Afonso-Reis, Ricardo; Afonso, Inês T.; Tomé, Sandra; Codêsso, José Miguel; et al. "A expressão da proteína G3BP1 reduz as anomalias neuropatológicas e motoras em modelos da Ataxia espinocerebelosa, tipo 3". Trabalho apresentado em Congresso SPDMov 2022, 2022.
  18. Carvalhas-Almeida, Catarina; Pereira de Almeida, Luis ; Cavadas, Claudia; Pedro Perdigão; Álvaro, Ana Rita. "Characterization iPSC-derived neuronal cells with potential for disease modeling of human insomnia". Trabalho apresentado em 12th International Meeting of the Portuguese Society for Stem Cells and Cell Therapies, 2022.
  19. Carvalhas de Almeida, Catarina; Pereira de Almeida, Luis ; Cavadas, Claudia; Perdigão, Pedro*; Álvaro, Ana Rita* . Autor correspondente: Perdigão, Pedro*. "Insomnia patient-derived iPSC neurons with potential for disease modeling". Trabalho apresentado em World Spleep Congress 2022, Rome, Italy, 2022.
  20. Carvalhas de Almeida, Catarina; Pereira de Almeida, Luis ; Cavadas, Claudia; Perdigão, Pedro*; Álvaro, Ana Rita* . Autor correspondente: Perdigão, Pedro*. "Establishing iPSC-derived neuronal cell model to study human insomnia pathophysiology". Trabalho apresentado em XVI Symposium of Experimental Biology and Biomedicine Doctoral Programme, University of Coimbra, Coimbra, Portugal, 2022.
  21. Serra, Beatriz; Sónia P. Duarte; Nathalie Cartier; Alves, Sandro; Pereira de Almeida, Luis ; Perfeito, Rita. Autor correspondente: Perfeito, Rita. "Intravenous delivery of the brain-targeting AAV-PHPeB encoding the cholesterol hydroxylase CYP46A1 into a mouse model of spinocerebellar ataxia type 3: a promising non-invasive therapeutic strategy". Trabalho apresentado em XVII Meeting of the Portuguese Society for Neuroscience, Coimbra, Portugal, 2021.
  22. Santos, D.; Santos, M. I.; Baganha, R.; Nobre, R.; Pereira de Almeida, L; Duarte, S.P.. Autor correspondente: Santos, D.. "Restoration Of Dysregulated MiRNA Levels In A Transgenic Mouse Model Of Machado Joseph Disease As A Novel Therapeutic Approach". Trabalho apresentado em XVII Congress of the Portuguese Society of Neuroscience, 2021.
  23. Koppenol, Rebekah; Conceição, André; Marcelo, Adriana; Afonso-Reis, Ricardo; Afonso, Inês T.; Codêsso, José Miguel; Matos, Carlos A; Pereira de Almeida, Luis ; Nóbrega, Clévio David Rodrigues. "G3BP1 expression mitigates pathological phenotype in mouse models different polyglutamine diseases". Trabalho apresentado em XVII Meeting of the Portuguese Society for Neuroscience (SPN), 2021.
  24. Rufino-Ramos, David; Kevin Leandro; Vitor Carmona; Inês M. Martins; Manuela Paolleta; Patrícia R. Albuquerque; Rosário Faro; et al. "Intranasal delivery of extracellular vesicles carrying silencing sequences alleviates Machado-Joseph Disease". Trabalho apresentado em XVII Meeting of the Portuguese Society for Neuroscience, 2021.
  25. Braz, Sandra O.; Catarina Vinhas; Henriques, Daniel; Moreira, Ricardo; Rosário Faro; Sónia P. Duarte; Pereira de Almeida, Luis; Liliana S. Mendonça. Autor correspondente: Liliana S. Mendonça. "Cerebellar transplantation of iPSC-derived neuroepithelial stem cells silenced for mutant ATXN3 for Machado-Joseph disease". Trabalho apresentado em Portuguese Society for Neuroscience - SPN 2021, 2021.
  26. Perdigão, Pedro; Matos, Carlos A; Lopes, Sara; Fernandes, Ana Rita; Lopes, Miguel; Faro, Rosário; Santana, Magda M; Nobre, Rui Jorge; Pereira de Almeida, Luis. "Precise and scarless correction of ATXN3-CAG expansion by CRISPR/Cas9 for the generation of patient-derived MJD isogenic iPSC". Trabalho apresentado em XVII Meeting of the Portuguese Society for Neuroscience, Coimbra, Portugal, 2021.
  27. Marcelo, Adriana; Afonso, Inês T.; Afonso-Reis, Ricardo; Brito, David V.C.; Costa, Rafael G.; Rosa, Ana; Alves-Cruzeiro, João; et al. "FROM MOLECULAR MECHANISMS TO THERAPY: A NEW LENTIVIRAL MOUSE MODEL FOR SPINOCEREBELLAR ATAXIA TYPE 2". Trabalho apresentado em XVII Meeting of the Portuguese Society for Neuroscience (SPN), 2021.
  28. Afonso-Reis, Ricardo; Koppenol, Rebekah; Conceição, André; Teixeira, Diogo; Marcelo, Adriana; Tomé, Sandra; Carmo-Silva, Sara; et al. "ASSESSING THE ROLE OF DIFFERENT G3BP1 REGIONS IN THE MITIGATION OF THE PATHOLOGICAL PHENOTYPE IN SCA2 AND SCA3 DISEASE MODELS". Trabalho apresentado em XVII Meeting of the Portuguese Society for Neuroscience (SPN), 2021.
  29. Henriques, Daniel; Moreira, Ricardo; Pedro Perdigão; Kirkeby, Agnete ; Pereira de Almeida, Luis ; Liliana S. Mendonça. "Generation of cerebellar neuronal progenitors for cell replacement strategies in Machado-Joseph Disease". Trabalho apresentado em XVII Meeting of the Portuguese Society for Neuroscience, 2021.
  30. Afonso-Reis, Ricardo; Koppenol, Rebekah; Conceição, André; Teixeira, Diogo; Marcelo, Adriana; Tomé, Sandra; Carmo-Silva, Sara; et al. "MAPPING THE DOMAINS OF RBP-X TOWARDS MITIGATION OF THE PATHOLOGICAL PHENOTYPE IN POLYGLUTAMINE DISEASE MODELS". Trabalho apresentado em IV Jornadas Algarve Biomedical Centre, 2021.
  31. Silva, Ana Carolina; Lobo, Diana Duarte; Henriques, Carina; Martins, Maria Inês; Lopes, Sara Monteiro; Duarte, Sónia; Wagner, E; Nobre, Rui Jorge; Pereira de Almeida, Luis Fernando Morgado. "Allele-specific silencing of Machado-Joseph disease using antisense oligonucleotide therapeutics". Trabalho apresentado em 1st Symposium on Oligonucleotide Technologies and Therapeutics@Portugal, 2021.
  32. Ferreira-Marques, Marisa; Cortes, Luísa; Valero, Jorge; Pereira, Dina; Pereira de Almeida, Luis ; Cavadas, Claudia; Aveleira, Célia. "Human Progeria fibroblasts in culture to study new strategies to delay aging". Trabalho apresentado em JRC Summer School on Non-Animal Approaches in Science: The Three R...evolution, 2021.
  33. Afonso, Inês T.; Carolina Silva, Ana; Henriques, Carina; Lopes, Miguel; Baganha, Rafael; Lima, Patrícia; Kopenol, Rebekah; et al. "Brain distribution, spreading and tropism of a recently developed gene delivery system - mixCapAAV1/2 vector". Trabalho apresentado em AIMS meeting 2021 Research Competition, 2021.
  34. Conceição, André; Koppenol, Rebekah; Marcelo, Adriana; Matos, Carlos A.; Ricardo Reis; Sandra Tomé; Diogo Teixeira; et al. "An RNA-binding protein alleviates pathology in two different mouse models of polyglutamine diseases.". Trabalho apresentado em 24th Annual Meeting of the Portuguese Society of Human Genetics, 2020.
  35. Magda M Santana; Silva, Patrick; Gaspar, Laetitia S; Pinto, Maria Manuel ; Carina Henriques; Joana Ribeiro; Inês Cunha; et al. "miRNA expression profile of plasma-derived extracellular from Machado-Joseph Disease patients.". Trabalho apresentado em SCA global and ARCA global, 2020.
  36. Marcelo, Adriana; Koppenol, Rebekah; Matos, Carlos A; Pereira de Almeida, Luis ; Nóbrega, Clévio David Rodrigues. "Striatal neuropathology in spinocerebellar ataxia type 2: a new lentiviral mouse model". Trabalho apresentado em FENS 2020 Virtual Forum, 2020.
  37. Liliana S. Mendonça; Henriques, Daniel; Vanessa Fernandes; Moreira, Ricardo; Vinhas, Ana C.; Rosário Faro; Duarte, Sónia; Jens C. Schwamborn; Pereira de Almeida, Luis. "Patient specific IPSC-derived neuroepithelial stem cells for cell-based therapy in Machado-Joseph disease". Trabalho apresentado em FENS 2020 Virtual Forum, 2020.
  38. Almeida, Sara F.F.; Lima, Nuno; Oliveira, Rui; Martins-Marques, Tânia; Ribeiro-Rodrigues, Teresa; Miranda, Catarina Oliveira; Pereira de Almeida, Luis Fernando Morgado; et al. "Preconditioning mice with osteosarcoma cells-derived secretome promote tumour cells engraftment and lung metastasis development". Trabalho apresentado em Tumor Microenvironment (EACR-AACR Basic and Translational Research Conference in partnership with ASPIC), 2020.
  39. Afonso-Reis, Ricardo; Koppenol, Rebekah; Pereira de Almeida, Luis ; Matos, Carlos A; Nóbrega, Clévio David Rodrigues. "Silencing ATXN2 expression using CRISPR/Cas9". Trabalho apresentado em 24th Annual Meeting of the Portuguese Society for Human Genetics (SPGH), 2020.
  40. Henriques, Carina S.; Lopes, M. M.; Albuquerque, PR; Rufino-Ramos, David; Gaspar, Laetitia; Lobo, Diana Duarte; Duarte, Sónia; et al. "Extracellular vesicles-associated AAVs as new gene delivery vectors for the treatment of brain disorders". Trabalho apresentado em 3rd BEB Day, 2019.
  41. Leandro, Kevin; Rufino-Ramos, David; Henriques, Carina S.; Pereira de Almeida, Luis Fernando Morgado. "Density Gradient Centrifugation: an improved protocol for Extracellular Vesicles isolation". Trabalho apresentado em 1 st Annual Meeting in Pharmaceutical Sciences, 2019.
  42. Leandro, Kevin; Rufino-Ramos, David; Henriques, Carina S.; Pereira de Almeida, Luis Fernando Morgado. "Isolation of functional extracellular vesicles by sucrose gradient centrifugation". Trabalho apresentado em BEBDay 2019, 2019.
  43. Almeida, Sara F.F.; Lima, Nuno; Oliveira, Rui; Martins-Marques, Tânia; Miranda, Catarina Oliveira; Pereira de Almeida, Luis Fernando Morgado; Amílcar, Falcão; Abrunhosa, Antero; Gomes, Célia. "Secretome derived from osteosarcoma (OS) cells promote tumour cell colonization and lung metastasis formation in pre-treated mice". Trabalho apresentado em CIBB Meeting 2019 - Universidade de Coimbra, 2019.
  44. Álvaro, Ana Rita ; Pereira de Almeida, Luis ; Nguyen, Hoa; Trottier, Yvon; Déglon, Nicole; Perrier, Anselme; Cattaneo, Elena. "Advanced Models of Polyglutamine Disorders (HD, SCA3, SCA7) - ModelPolyQ". Trabalho apresentado em JPND/JPco-fuND final symposium, 2019.
  45. Marques, Andreia; Rufino-Ramos, David; Henriques, Carina; Schwamborn, Jens C.; Perfeito, Rita; Pereira de Almeida, Luis. "Intercellular Transport of Alpha-Synuclein in the context of Parkinson¿s Disease". Trabalho apresentado em 1st Annual Meeting in Pharmaceutical Sciences, 2019.
  46. Lopes, Sara M; Matos, Carlos Adriano; Conceição, André; Pena, Frederico; Lopes, Miguel Monteiro; Nobre, Rui Jorge; Nóbrega, Clévio; et al. "CRISPR-Cas9 systems targeting ATXN3 as therapeutic approaches for Machado-Joseph Disease". Trabalho apresentado em International Ataxia Research Conference (IARC 2019), 2019.
  47. Silva, P.; Santana, Magda Matos; Cunha, Inês; Ribeiro, Joana; Pereira, Dina; Gaspar, Laetitia; Januário, Cristina; Pereira de Almeida, Luis. "Portuguese-mainland cohort of Machado-Joseph Disease: what can be seen after one-year follow-up?". Trabalho apresentado em 1st Annual Meeting in Pharmaceutical Sciences, 2019.
  48. Rui Jorge Nobre; Lobo, Diana Duarte; Catarina Oliveira Miranda; Pereira, Dina; Castelhano, Joao; Sereno, José Vitor Oliveira; Castelo-Branco, Miguel; Pereira de Almeida, Luis Fernando Morgado. "Blood-brain barrier dysfunction in spinocerebellar ataxia type 3 (Machado-Joseph disease): Results from mouse and human brain tissues". Trabalho apresentado em XVI Meeting of the Portuguese Society for Neuroscience, 2019.
  49. Aveleira, Célia; Ferreira-Marques, Marisa; Cortes, Luísa; Valero, Jorge; Pereira, Dina; Pereira de Almeida, Luis Fernando Morgado; Cavadas, Claudia. "Neuropeptide Y enhances progerin clearance and delays cellular senescence in human Hutchinson-Gilford Progeria Syndrome cells.". Trabalho apresentado em 3rd Molecular Biology of Ageing Meeting, European Research Institute for the Biology of Ageing (ERIBA), University Medical Center Groningen, Groningen, The Netherlands., 2019.
  50. Lopes, Miguel Monteiro; Paysan, Jacques; Rino, José; Lopes, Sara Monteiro; Nobre, Rui Jorge; Cortes, Luisa; Pereira de Almeida, Luis Fernando Morgado; et al. "Whole-Brain Analysis of Adeno-Associated Virus (AAV) Biodistribution with Single-Cell Resolution by Tissue Clearing and Light-Sheet Microscopy". Trabalho apresentado em EMBO | EMBL Symposium: Seeing Is Believing ¿ Imaging the Molecular Processes of Life, 2019.
  51. Almeida, Sara F.F.; Lima, Nuno; Martins-Marques, Tânia; Girao, Henrique; Miranda, Catarina Oliveira; Pereira de Almeida, Luis Fernando Morgado; Amílcar, Falcão; Abrunhosa, Antero; Gomes, Célia. "Osteosarcoma-released bioactive factors facilitate lung metastasis by regulating cell adhesion". Trabalho apresentado em Seed and Soil: mechanisms of metastasis (2nd joint EACR-MRS conference), 2019.
  52. Carmo-Silva, Sara; Nóbrega, Clévio; Ferreira-Marques, Marisa; Botelho, Mariana; Pulst, Stefan M; Pereira de Almeida, Luis Fernando Morgado; Cavadas, Claudia. "Resetting the clock on obesity: The tale of Hypothalamic Ataxin-2". Trabalho apresentado em Gordon Research Seminar on Clocks in Model Organisms: Circadian Networks, Physiology and Health, 2019.
  53. Aveleira, Célia; Ferreira-Marques, Marisa; Cortes, Luísa; Valero, Jorge; Pereira, Dina; Pereira de Almeida, Luis Fernando Morgado; Cavadas, Claudia. "Neuropeptide Y ameliorates the aging phenotype of Hutchinson-Gilford Progeria Syndrome cells.". Trabalho apresentado em Ageing: models, mechanisms and therapies Conference, Faculty of Medicine, University of Coimbra, Coimbra, Portugal., 2019.
  54. Marcelo, Adriana; Tomé, Sandra; Carmo-Silva, Sara; Ferreira, Marco; Teixeira, Diogo; Matos, Carlos A; Koppenol, Rebekah; Pereira de Almeida, Luis Fernando Morgado; Nóbrega, Clévio. "RNA-binding proteins: new molecular targets for Polyglutamine diseases?". Trabalho apresentado em XVI Meeting of the Portuguese Society of Neurosciences, 2019.
  55. Koppenol, Rebekah; Marcelo, Adriana; Matos, Carlos A; Carmo-Silva, Sara; Pereira de Almeida, Luis Fernando Morgado; Nóbrega, Clévio. "On the role of stress granules in autophagy". Trabalho apresentado em XVI Meeting of the Portuguese Society of Neurosciences, 2019.
  56. Perfeito, Rita; Anjos, Vanessa; Marques, Andreia; Garrido, Manuel; Schwamborn, Jens C.; Pereira de Almeida, Luis. "Intersection of Exosome Secretion and Autophagy on Alpha-Synuclein Spreading Profile in Parkinson¿s Disease Cell Models". Trabalho apresentado em XVI Meeting of the Portuguese Society for Neuroscience, 2019.
  57. Nóbrega, Clévio David Rodrigues ; Mendonça, Liliana; Marcelo, Adriana; Lamazière, Antonin; Tomé, Sandra; Despres, Gaetan; Matos, Carlos A; et al. "CYP46A1 - Gene therapy alleviates Machado-Joseph disease". Trabalho apresentado em XVI Meeting of Portuguese Society for Neuroscience (SPN2019), 2019.
  58. Miranda, Catarina Oliveira; Marcelo, Adriana; Silva, Teresa P.; Barata, João; Vasconcelos-Ferreira, Ana; Pereira, Dina; Duarte, Sónia; et al. "Sustainable phenotypic ameliorations in Machado-Joseph Disease/Spinocerebelar ataxia type-3 can be reached by repeated systemic administrations of mesenchymal stromal cells ¿ and can be monitored through proton Magnetic Resonance Spectroscopy biomarkers.". Trabalho apresentado em XVI Meeting of the Portuguese Society for Neuroscience (SPN2019), 2019.
  59. Santana, Magda M; Silva, P.; Ribeiro, Joana; Cunha, Inês; Gaspar, Laetitia; Januário, Cristina; Pereira de Almeida, Luis. "Characterization of the Coimbra cohort of Machado-Joseph Disease patients for future clinical trials". Trabalho apresentado em 1st SCA Global Conference, 2019.
  60. Carmo-Silva, Sara; Clévio, Nóbrega; Ferreira-Marques, Marisa; Botelho, Mariana; Aveleira, Célia; Pulst, Stefan M; Pereira de Almeida, Luis Fernando Morgado; Cavadas, Claudia. "Hypothalamic ataxin-2 at the crossroads of metabolism and circadian rhythm". Trabalho apresentado em Chrononutrition: From Epidemiology to Molecular Mechanism Symposium, 2018.
  61. Nobre, Rui Jorge; Saraiva, Joana; Fusco, Clelia; Paixão, Susana; Santana, Magda M; Petrella, Lorena; Castelhano, João; et al. "Non-invasive allele-specific silencing therapy and biomarkers for Machado-Joseph disease". Trabalho apresentado em 26th Annual Congress of European Society of Gene and Cell Therapy, 2018.
  62. Miranda, Catarina Oliveira; Nobre, Rui Jorge; Paiva, Vitor H; Castelhano, João; Petrella, Lorena I; Sereno, José; Castelo-Branco, Miguel; Pereira de Almeida, Luis Fernando Morgado. "Assessing cerebellar neurometabolic biomarkers by in vivo Magnetic Resonance Spectroscopy in a transgenic mouse model of Machado-Joseph disease". Trabalho apresentado em 26th Annual Congress of European Society of Gene and Cell Therapy, 2018.
  63. Tomé, Sandra; Marcelo, Adriana; Carmo-Silva, Sara; Ferreira, Marco; Pereira de Almeida, Luis ; Nóbrega, Clévio David Rodrigues. "RNA-binding proteins in Polyglutamine diseases: from pathogenesis to molecular therapy". Trabalho apresentado em 11th Forum of Neuroscience (FENS), 2018.
  64. Carmo-Silva, Sara; Clévio, Nóbrega; Ferreira-Marques, Marisa; Botelho, Mariana; Aveleira, Célia; Pulst, Stefan M; Pereira de Almeida, Luis Fernando Morgado; Cavadas, Claudia. "Hypothalamic ataxin-2 a novel regulator of circadian rhythm". Trabalho apresentado em EMBO|EMBL Symposium: Biological Oscillators: Design, Mechanism, Function, 2018.
  65. Nobre, Rui Jorge; Saraiva, Joana; Fusco, Clelia; Paixão, Susana; Santana, Magda M; Petrella, Lorena; Castelhano, João; et al. "Non-Invasively Silencing and Monitoring Machado-Joseph Disease". Trabalho apresentado em The American Society of Gene & Cell Therapy meeting, 2018.
  66. Albuquerque, Patricia Rosado; Santana, Magda M; Nobre, Rui Jorge; Miranda, Catarina Oliveira; Lopes, Sara Monteiro; Ribeiro-Rodrigues, Teresa; Girao, Henrique; Gomes, Célia; Pereira de Almeida, Luis Fernando Morgado. "Non-invasive delivery with hybrid extracelular vesicles for therapy of Machado Joseph-disease". Trabalho apresentado em International Society for Extracellular Vesicles Annual Meeting, 2018.
  67. Santana, Magda M; Gaspar, Laetitia; Perfeito, Rita; Albuquerque, Patrícia; Ribeiro-Rodrigues, Teresa; Girao, Henrique; Nobre, Rui Jorge; et al. "Optimization of a size exclusion chromatography protocol to isolate plasma-derived extracelular vesicles for transcriptional biomarkers research". Trabalho apresentado em International Society for Extracellular Vesicles Annual Meeting, 2018.
  68. Miranda, Catarina Oliveira; Machado, Adriana; Silva, T.; Barata, João; Vasconcelos-Ferreira, Ana; Pereira, Dina; Duarte, Sónia; et al. "Repeated treatment with mesenchymal stromal cells sustainably alleviates Machado-Joseph Disease and Its Efficacy Can Be Monitored With Neurospectroscopic Biomarkers". Trabalho apresentado em 1st international symposium Secretome With]Out[ Borders, 2018.
  69. Nobre, Rui Jorge; Saraiva, Joana; Fusco, Clelia; Paixão, Susana; Santana, Magda M; Sena-Esteves, Miguel; Pereira de Almeida, Luis Fernando Morgado. "Non-invasive and allele-specific silencing of mutant ataxin-3 alleviates neuropathology and motor deficits of Machado-Joseph disease.". Trabalho apresentado em IARC 2017 Conference - 2nd International Ataxia Research Conference, 2017.
  70. Miranda, Catarina Oliveira; Machado, Adriana; Silva, T.; Barata, João; Pereira, Dina; Vasconcelos-Ferreira, Ana; Nobrega, Clévio; et al. "Repeated treatment with mesenchymal stromal cells sustainably alleviates Machado-Joseph Disease/Spinocerebellar ataxia type-3 through neuroprotection of GABAergic neurons". Trabalho apresentado em 10th International Meeting of the Portuguese Society for Stem Cells and Cell Therapies (SPCE-TC), 2017.
  71. Lopes, Sara Monteiro; Nobre, Rui Jorge; Nobrega, Clévio; Lopes, Miguel Monteiro; Matos, Carlos Adriano; Sanjana, Neville; Hsu, Patrick; et al. "TALEN and CRISPR gene-editing for treatment of Machado-Joseph disease". Trabalho apresentado em 2nd International Ataxia Research Conference (IARC 2017), 2017.
  72. Miranda, Catarina Oliveira; Machado, Adriana; Silva, T.; Barata, João; Nobrega, Clévio; Duarte, Sónia; Nobre, Rui Jorge; et al. "Repeated systemic injection of mesenchymal stem cells sustainably alleviates motor impairments and mitigates neuropathology in Machado-Joseph disease". Trabalho apresentado em XV Meeting of the Portuguese Society for Neurosciences, 2017.
  73. Nobre, Rui Jorge; Saraiva, Joana; Fusco, Clelia; Paixão, Susana; Santana, Magda M; Sena-Esteves, Miguel; Pereira de Almeida, Luis Fernando Morgado. "Non-invasive AAV9-mediated silencing of mutant ataxin-3 alleviates motor and neuropathological deficits in a transgenic mouse model of Machado-Joseph disease". Trabalho apresentado em 24th Annual Congress of European Society of Gene and Cell Therapy, 2016.
  74. Aveleira, Célia; Botelho, Mariana; Cortes, Luísa; Valero, Jorge; Pereira, Dina; Pereira de Almeida, Luis Fernando Morgado; Cavadas, Claudia. "Neuropeptide Y rescues the senescent phenotype of human Hutchinson-Gilford Progeria Syndrome cells.". Trabalho apresentado em Cell Symposia ¿ Aging and Metabolism, Sitges, Spain., 2016.
  75. Gonçalves, Nélio; Machado, Nuno J.; Souza, Carolina M.; Fernandes, Sara B.; Simões, Ana; Simões, Ana; Pereira de Almeida, Luis Fernando Morgado; Cunha, R. A.. "Selective amygdala neuronal down-regulation of adenosine A2A receptors prevents mood-related modifications". Trabalho apresentado em The 7th International Society of Neurochemistry Conference: Synaptic function and dysfunction in brain diseases, 2016.
  76. Simões, Ana; Machado, Nuno J.; Gonçalves, Nélio; Kaster, Manuella; Simões, Ana; Nunes, Ana; Pereira de Almeida, Luis Fernando Morgado; et al. "Adenosine A2A receptors in the amygdala control synaptic plasticity and fear memory". Trabalho apresentado em The 7th International Society of Neurochemistry Conference: Synaptic function and dysfunction in brain diseases, 2016.
  77. Perfeito, Rita; Anjos, Vanessa; Nobre, Rui Jorge; Garrido, Manuel; Pereira de Almeida, Luis Fernando Morgado. "Autophagy activation prevents alpha-synuclein secretion in exosomes". Trabalho apresentado em Annual Meeting ¿ ISEV, 2016.
  78. Carmo-Silva, Sara; Nóbrega, Clévio; Ferreira-Marques, Marisa; Botelho, Mariana; Aveleira, Célia; Pulst, Stefan; Pereira de Almeida, Luis Fernando Morgado; Cavadas, Claudia. "Hypothalamic ataxin-2: a new player in central regulation of regulation of energy balance.". Trabalho apresentado em EMBO Workshop ¿ Neural control of metabolism and eating behavior, Cascais, Portugal., 2016.
  79. Aveleira, Célia; Cortes, Luísa; Ferreira-Marques, Marisa; Leal, Ana; Valero, Jorge; Pereira, Dina; Pereira de Almeida, Luis Fernando Morgado; Cavadas, Claudia. "Ghrelin enhances progerin clearance and rescues the senescent phenotype of human Hutchinson-Gilford Progeria Syndrome cells.". Trabalho apresentado em 8th Progeria Research Foundation International Scientific Workshop ¿ Across the Table, Around the Globe, Cambridge, MA, USA., 2016.
  80. Petrella, Li; Sereno, José V; Miranda, Catarina; Nobre, Rui Jorge; Castelhano, João; Pereira de Almeida, Luis Fernando Morgado; Castelo-Branco, Miguel. "Evaluation of brain structures volumes on a transgenic mouse model of Machado-Joseph disease". Trabalho apresentado em VII Annual Meeting of IBILI, 2015.
  81. Carmo-Silva, Sara; Nóbrega, Clévio; Ferreira-Marques, Marisa; Botelho, Mariana; Aveleira, Célia; Álvaro, Ana Rita ; Pulst, Stefan; Pereira de Almeida, Luis Fernando Morgado; Cavadas, Claudia. "Ataxin-2 in the hypothalamus: a novel regulator of energy balance and metabolism.". Trabalho apresentado em XIII CNC Annual Meeting, Coimbra, Portugal., 2015.
  82. Mendonça, Liliana; Onofre, Isabel; Nóbrega, Clévio; Nobre, Rui Jorge; Pereira de Almeida, Luis Fernando Morgado. "Generation of gene-silenced human iPS-derived NSC for transplantation in Machado Joseph Disease". Trabalho apresentado em World conference on regenerative medicine, 2015.
  83. Botelho, Mariana; Aveleira, Célia; Carmo-Silva, Sara; Pascoal, Jorge; Ferreira-Marques, Marisa; Nóbrega, Clévio; Cortes, Luísa; et al. "Neuropeptide Y1 and Y5 receptors activation stimulate autophagic flux in mouse hypothalamic neurons.". Trabalho apresentado em 11th NPY-PYY-PP International Meeting, Leipzig, Germany., 2015.
  84. Carmo-Silva, Sara; Nóbrega, Clévio; Ferreira-Marques, Marisa; Botelho, Mariana; Álvaro, Ana Rita ; Aveleira, Célia; Pulst, Stefan; Pereira de Almeida, Luis Fernando Morgado; Cavadas, Claudia. "Impact of hypothalamic ataxin-2 on energy balance and metabolic profile.". Trabalho apresentado em 9th IBRO World Congress on Neuroscience, Rio de Janeiro, Brazil., 2015.
  85. Aveleira, Célia; Cortes, Luísa; Valero, Jorge; Pereira, Dina; Pereira de Almeida, Luis Fernando Morgado; Cavadas, Claudia. "Neuropeptide Y enhances progerin clearance and rescues the senescent phenotype of human Hutchinson-Gilford Progeria Syndrome fibroblasts.". Trabalho apresentado em The Translational Science of Aging: From Functional Pathways to Interventions Gordon Research Conference on Biology of Aging, Sunday River, Newry, USA., 2015.
  86. Aveleira, Célia; Carmo-Silva, Sara; Botelho, Mariana; Ferreira-Marques, Marisa; Nóbrega, Clévio; López-Ótin, Carlos; Pereira de Almeida, Luis Fernando Morgado; Cavadas, Claudia. "Neuropeptide Y rescues the aging phenotype of a mouse model of human premature aging.". Trabalho apresentado em The Translational Science of Aging: From Functional Pathways to Interventions Gordon Research Conference on Biology of Aging, Sunday River, Newry, USA., 2015.
  87. Botelho, Mariana; Aveleira, Célia; Carmo-Silva, Sara; Pascoal, Jorge; Ferreira-Marques, Marisa; Nóbrega, Clévio; Cortes, Luísa; et al. "Autophagy in the hypothalamus: the role of Neuropeptide Y.". Trabalho apresentado em 9th IBRO World Congress on Neuroscience, Rio de Janeiro, Brazil., 2015.
  88. Carmo-Silva, Sara; Nóbrega, Clévio; Botelho, Mariana; Ferreira-Marques, Marisa; Aveleira, Célia; Pulst, Stefan; Pereira de Almeida, Luis Fernando Morgado; Cavadas, Claudia. "Hypothalamic ataxin-2 regulates energy balance and metabolism.". Trabalho apresentado em Neural Control of Metabolic Physiology and Diseases Keystone Symposia on Molecular and Cellular Biology, Snowbird, Utah, USA., 2015.
  89. Gonçalves, Nélio; Simões, Ana; Prediger, R.D.; Cunha, R.A.; Pereira de Almeida, Luis Fernando Morgado. "Caffeine alleviates progressive motor deficits in Machado-Joseph disease transgenic mice". Trabalho apresentado em Ataxia Research Conference 2015, 2015.
  90. Albuquerque, Patrícia; Nobre, Rui Jorge; Pereira de Almeida, Luis Fernando Morgado. "Polyglutamine expansion in the human ataxin-3 protein changes the extracellular vesicles RNA and protein content". Trabalho apresentado em First Iberian meeting on extracelular vesicles, 2015.
  91. Onofre, Isabel; Mendonça, Nuno; Lopes, Sara; Nobre, Rui Jorge; Barbosa, Joana; Carreira, Isabel M; Carvalho, Lina; et al. "Characterization of a human Machado-Joseph Disease neuronal cell model derived from induced pluripotent stem cells". Trabalho apresentado em 9th Annual meeting of the Portuguese Society for Stem Cells and Cell Therapies, 2015.
  92. Lopes, Sara; Nobre, Rui Jorge; Nobrega, Clévio; Sanjana, Neville; Cong, Le; Hsu, Patrick; Ran, Fei Ann; Zhang, Feng; Pereira de Almeida, Luis Fernando Morgado. "Gene editing strategies towards Machado Joseph disease". Trabalho apresentado em EMBO workshop: "Modern DNA concepts and tools for safe gene transfer and modification", 2015.
  93. Duarte-Neves, Joana; Gonçalves, Nélio; Cunha-Santos, Janete; Simões, Ana; den Dunnen, W.F.A.; Cavadas, Claudia; Pereira de Almeida, Luis Fernando Morgado. "Therapeutic role of neuropeptide Y in mouse models of Machado-Joseph disease". Trabalho apresentado em XII Annual Meeting of the Center for Neuroscience and Cell Biology, 2014.
  94. Carmona, Vitor; Cunha-Santos, Janete; Simões, Ana; Pereira de Almeida, Luis Fernando Morgado. "Ataxin-3 3¿UTR reduces neuropathology in a lentiviral mouse model of Machado-Joseph disease ¿ a role for microRNAs ?". Trabalho apresentado em XII Annual Meeting of the Center for Neuroscience and Cell Biology, 2014.
  95. Aveleira, Célia; Botelho, Mariana; Carmo-Silva, Sara; Sousa-Ferreira, Lígia; Ferreira-Marques, Marisa; Nóbrega, Clévio; López-Otín, Carlos; Pereira de Almeida, Luis Fernando Morgado; Cavadas, Claudia. "Neuropeptide Y rescues the phenotype of a mousse model of human premature aging". Trabalho apresentado em XII CNC Annual Meeting, University of Coimbra, Coimbra, Portugal, 2014.
  96. Nóbrega, Clévio; Carmo-Silva, Sara; Pereira de Almeida, Luis Fernando Morgado. "Translational inhibition in Machado-Joseph disease: Ataxin-2 as a new molecular target". Trabalho apresentado em 5th Ataxia Investigators Meeting (AIM), 2014.
  97. Albuquerque, Patricia; Nobre, Rui Jorge; Pereira de Almeida, Luis Fernando Morgado. "POLYGLUTAMINE EXPANSION IN THE HUMAN ATAXIN3 PROTEIN CHANGES THE EXOSOMAL microRNA CONTENT OF NEURONAL CELLS". Trabalho apresentado em 2nd Geivex Symposium Extracellular vesicles: From the bench to the clinics, 2014.
  98. Nóbrega, Clévio; Carmo-Silva, Sara; Pereira de Almeida, Luis Fernando Morgado. "Ataxin-2 as a new molecular target for Machado-Joseph Disease". Trabalho apresentado em Champalimaud Neuroscience Programme Symposium, 2013.
  99. Aveleira, Célia; Botelho, Mariana; Pascoal, Jorge; Carmo-Silva, Sara; Nóbrega, Clévio; Sousa-Ferreira, Lígia; Álvaro, Ana Rita ; et al. "Neuropeptide Y, a caloric restriction mimetic, induces autophagy in hypothalamic neurons.". Trabalho apresentado em EMBO Young Scientists¿ Forum, Lisbon, Portugal, 2013.
  100. Aveleira, Célia; Botelho, Mariana; Carmo-Silva, Sara; Sousa-Ferreira, Lígia; Ferreira-Marques, Marisa; Nóbrega, Clévio; López-Otín, Carlos; Pereira de Almeida, Luis Fernando Morgado; Cavadas, Claudia. "Neuropeptide Y ameliorates the phenotype of a mousse model of human premature aging". Trabalho apresentado em 7th Progeria Research Foundation International Workshop ¿ Hand in Hand: Basic and Clinical Science Working Together Toward the Cure, Bethesda, MD, USA, 2013.
  101. Aveleira, Célia; Botelho, Mariana; Carmo-Silva, Sara; Sousa-Ferreira, Lígia; Ferreira-Marques, Marisa; Nóbrega, Clévio; López-Otín, Carlos; Pereira de Almeida, Luis Fernando Morgado; Cavadas, Claudia. "Neuropeptide Y ameliorates the phenotype of a mouse model of human premature aging.". Trabalho apresentado em 7th Progeria Research Foundation International Workshop ¿ Hand in Hand: Basic and Clinical Science Working Together Toward the Cure, Bethesda, MD, USA, 2013.
  102. Simões, Ana Teresa; Gonçalves, Nélio; Nobre, Rui Jorge; Duarte, Carlos B.; Pereira de Almeida, Luis Fernando Morgado. "Orally-administered calpain inhibitor BDA-410 reduces ataxin-3 cleavage and alleviates neuropathology in a lentiviral mouse model of Machado-Joseph disease". Trabalho apresentado em XIII REunião da Sociedade Portuguesa de neurociências, 2013.
  103. Botelho, Mariana; Aveleira, Célia; Pascoal, Jorge; Carmo-Silva, Sara; Sousa-Ferreira, Lígia; Nóbrega, Clévio; Álvaro, Ana Rita ; et al. "Neuropeptide Y is an autophagy inducer in hypothalamic neurons". Trabalho apresentado em X CNC Meeting, 2012.
  104. Botelho, Mariana; Aveleira, Célia; Sousa-Ferreira, Lígia; Jorge, Pascoal; Nóbrega, Clévio; Álvaro, Ana Rita ; Pereira de Almeida, Luis Fernando Morgado; Cavadas, Claudia. "Role of NPY on autophagy in hypothalamus: a caloric restriction mimetic?". Trabalho apresentado em 10th International NPY-PYY-PP Meeting, Montreal, Canada, 2012.
  105. Nobre, Rui Jorge; Herraez-Hernandez, Elsa; Fei, Jian-Wei; Cruz, Eugénia; Real, Odete; Langbein, Lutz; Kaden, Sylvia; et al. "Unraveling the role of common, rare and novel human papillomaviruses in the pathogenesis of cervical cancer". Trabalho apresentado em 16th International Charles Heidelberger Symposium on Cancer Research, 2010.
  106. Simões, Ana Teresa Antunes; Gonçalves, Nélio; Kügler, Sebastian; Duarte, Carlos B.; Pereira de Almeida, Luis Fernando Morgado. "Calpain-mediated proteolysis promotes mutant ataxin-3 translocation to the nucleus and neurodegeneration.". Trabalho apresentado em The Biology of Calpains in Health and Disease, 2010.
  107. Nobre, Rui Jorge; Pereira de Almeida, Luis Fernando Morgado; Saraiva, Joana; Fusco, Clelia; Paixão, Susana; Santana, Magda M; Sena-Esteves, Miguel. "Silencing Machado-Joseph disease through the systemic route". Trabalho apresentado em Workshop ¿Molecular Mechanisms in Neurodegeneration: From Molecule to Cures.", 2010.
  108. Gonçalves, Nélio; Simões, Ana Teresa Antunes; Cunha, Rodrigo A.; Pereira de Almeida, Luis Fernando Morgado. "Antagonism of adenosine A2A receptors provides neuroprotection in a lentiviral mouse model of Machado-Joseph disease.". Trabalho apresentado em Neuroscience 2009, 39th Annual Meeting of the Society for Neuroscience., 2009.
  109. Simões, Ana Teresa Antunes; Gonçalves, Nélio; Cunha, Rodrigo A.; Pereira de Almeida, Luis Fernando Morgado. "Calpains promote mutant ataxin-3 translocation to the nucleus and neurodegeneration.". Trabalho apresentado em Neuroscience 2009, 39th Annual Meeting of the Society for Neuroscience, 2009.
  110. Gonçalves, Nélio; Simões, Ana Teresa Antunes; Pereira de Almeida, Luis Fernando Morgado. "Inhibition of mutant ataxin-3 proteolysis by calpains in a lentiviral mouse model of Machado-Joseph disease.". Trabalho apresentado em XI Annual Meeting of the Portuguese Society for Neuroscience, 2009.
  111. Gonçalves, Nélio; Simões, Ana Teresa Antunes; Cunha, Rodrigo A.; Pereira de Almeida, Luis Fernando Morgado. "Adenosine A2A receptors antagonism delays neurodegeneration in a lentiviral mouse model of Machado-Joseph disease.". Trabalho apresentado em IV Meeting on the Molecular Mechanisms of Neurodegeneration, 2009.
  112. Simões, Ana Teresa Antunes; Gonçalves, Nélio; Déglon, Nicole; Kügler, Sebastian; Duarte, Carlos B.; Pereira de Almeida, Luis Fernando Morgado. "Inhibition of calpains prevents translocation of mutant ataxin-3 to the nucleus and reduces neurodegeneration in a lentiviral mouse model of Machado-Joseph Disease". Trabalho apresentado em IV Meeting on the Molecular Mechanisms of Neurodegeneration, 2009.
  113. Simões, Ana; Nóbrega, Clévio; Déglon, Nicole; Duarte, Carlos B.; Kügler, Sebastian; Pereira de Almeida, Luis Fernando Morgado. "Inhibition of calpains in a lentiviral mouse model of Machado-Joseph Disease". Trabalho apresentado em Lentiviral vectors: concepts, practice, hope and reality, 2008.
  114. Nobre, Rui Jorge; Pereira de Almeida, Luis Fernando Morgado; Martins, Teresa. "Cervical Cancer: factors modulating susceptibility and resistance to cancer development". Trabalho apresentado em IV Reunião do Centro de Neurociências e Biologia Celular da Universidade de Coimbra, 2006.
  115. Nobre, Rui Jorge; Prazeres, H; Real, O; Cruz, E.; Figueiredo, P.; Lacerda, M; Pereira de Almeida, Luis Fernando Morgado; Martins, Teresa. "Genotype spectrum of Human Papillomavirus infection in Portuguese population: detection of HPV type 53 and 67 in cervical cancer". Trabalho apresentado em 23rd International Conference and Clinical Workshop on Papillomavirus, 2006.
Resumo em conferência
  1. Beatriz Machado Serra; Duarte, Sónia; Nathalie Cartier; Sandro Alves; Pereira de Almeida, Luis ; Rita Perfeito. Autor correspondente: Rita Perfeito. "Systemic delivery of the brain-targeting AAV-PHPeB encoding the cholesterol hydroxylase CYP46A1 into a mouse model of Machado-Joseph disease: a promising therapeutic strategy". Trabalho apresentado em 29th Annual Congress of the European-Society-of-Gene-and-Cell-Therapy (ESCGT), Edinburgh, 2022.
    Publicado
  2. Conceição, André; Koppenol, Rebekah; Tomé, Sandra; Carmo-Silva, Sara; Matos, Carlos A; Pereira de Almeida, Luis Fernando Morgado; Nóbrega, Clévio David Rodrigues. "A RNA binding protein alleviates pathology in two different mouse models of polyglutamine diseases.". Trabalho apresentado em 24th Anual Meeting of Portuguese Human Genetics Society. Proceedings published in Medicine, 2021.
    Publicado • 10.1097/MD.0000000000023585
  3. Carmo-Silva, Sara; Nóbrega, Clévio David Rodrigues ; Ferreira-Marques, Marisa; Botelho, Mariana; Pulst, Stefan M; Pereira de Almeida, Luis Fernando Morgado; Cavadas, Claudia. "Hypothalamic ataxin-2 prevents obesity through the regulation of the circadian clock.". Trabalho apresentado em European and International Congress of Obesity 2020 (ECO-ICO). Proceedings published in Obesity Reviews, 2020.
    Publicado • DOI: 10.1111/obr.13115
  4. Afonso, Inês T.; Silva, Ana Carolina; Henriques, Carina; Lopes, Miguel; Baganha, Rafael; Lima, Patricia; Koppenol, Rebekah; et al. "mixCapAAV1/2 Vector: Distribution, Spreading and Tropism Analysis in Normal Mice". Trabalho apresentado em 24th Annual Meeting of the PortugueseSociety for Human Genetics (SPGH), Lisboa, 2020.
  5. Bras, A; Cunha, I; Silva, Patrick; Ribeiro, JA; Santana, MM; Pereira de Almeida, L; Januário, Cristina. "Characterization of a Portuguese cohort of Machado-Joseph disease: besides ataxia". Trabalho apresentado em 5th Congress of the European Academy of Neurology (EAN), Oslo, 2019.
    Publicado
  6. Carmo-Silva, Sara (9D11-2BDFA256); Nóbrega, Clévio David Rodrigues ; Ferreira-Marques, Marisa; Pulst, Stefan M; Pereira de Almeida, Luis ; Cavadas, Claudia. "Hypothalamic ataxin-2: Resetting the clock on obesity". Trabalho apresentado em 26th European Congress on Obesity, Gasglow, 2019.
    Publicado
  7. Nobre, Rui Jorge; Saraiva, Joana; Susana, Paixão; Fusco, Clelia; Santana, Magda M; Miranda, Catarina Oliveira; Lorena, Petrella; et al. "A miRNA-based gene therapy approach to knock-down mutant ATXN3: Alleviation of Machado-Joseph disease phenotype in two mouse models upon two routes of administration". Trabalho apresentado em EUROPEAN JOURNAL OF CLINICAL INVESTIGATION, 2019.
    Publicado
  8. Perfeito, Rita; Anjos, Vanessa; Marques, Andreia; Nobre, Rui Jorge; Manuel, Garrido; Christian, Scwamborn Jens; Pereira de Almeida, Luis Fernando Morgado. "Intersection of exosome secretion and autophagy on alpha-synuclein spreading profile in Parkinson¿s disease cell models. EUROPEAN JOURNAL OF CLINICAL INVESTIGATION". 2018.
    Publicado
  9. Albuquerque, Patrícia; Santana, Magda M; Nobre, Rui Jorge; Miranda, Catarina Oliveira; Lopes, Sara; Ribeiro-Rodrigues, TM; Girao, Henrique; Gomes, Célia; Pereira de Almeida, Luis Fernando Morgado. "Non-invasive brain delivery with hybrid extracellular vesicles (EVs) for therapy of Machado-Joseph disease (MJD), Journal of Extracellular Vesicles". 2018.
    Publicado
  10. Gaspar, Laetitia; Santana, Magda M; Perfeito, Rita; Albuquerque, Patrícia; Ribeiro-Rodrigues, Teresa M; Girao, Henrique; Nobre, Rui Jorge; Pereira de Almeida, Luis Fernando Morgado. "Optimization of a size-exclusion chromatography protocol to isolate plasma-derived extracellular vesicles for transcriptional biomarkers research, Journal of Extracellular Vesicles". 2018.
    Publicado
  11. Lopes, Sara; Nobre, Rui Jorge; Nobrega, Clévio; Lopes, Miguel; Matos, Carlos; Sanjana, Neville; Hsu, Patrick; et al. "TALEN and CRISPR Gene-Editing for Treatment of Machado-Joseph Disease, Molecular Therapy". 2018.
    Publicado
  12. Nobre, Rui Jorge; Saraiva, Joana; Fusco, Clelia; Paixão, Susana; Santana, Magda M; Petrella, Lorena; Sereno, José; et al. "Non-Invasively Silencing and Monitoring Machado-Joseph Disease. Molecular Therapy". 2018.
    Publicado
  13. Miranda, Catarina Oliveira; Marcelo, Adriana; Silva, TP; Barata, João; Vasconcelos-Ferreira, Ana; Pereira, Dina; Duarte, Sónia; et al. "Repeated mesenchymal stromal cells treatment sustainably alleviates Machado-Joseph disease/spinocerebellar ataxia type-3, Human Gene Therapy". 2018.
    Publicado
  14. Nobre, Rui Jorge; Saraiva, Joana; Fusco, Clelia; Paixão, Susana; Santana, Magda M; Petrella, Lorena; Sereno, José; et al. "Non-invasive allele-specific silencing therapy and biomarkers for Machado-Joseph disease, Human Gene Therapy". 2018.
    Publicado
  15. Miranda, Catarina Oliveira; Nobre, Rui Jorge; Paiva, VH; Castelhano, João; Petrella, Lorena; Sereno, José; Castelo-Branco, Miguel; Pereira de Almeida, Luis Fernando Morgado. "Assessing cerebellar neurometabolic biomarkers by in vivo magnetic resonance spectroscopy in a transgenic mouse model of Machado-Joseph disease. HUMAN GENE THERAPY". 2018.
    Publicado
  16. Miranda, Catarina Oliveira; Marcelo, Adriana; Silva, TP; Barata, João; Vasconcelos-Ferreira, Ana; Pereira, Dina; Duarte, Sónia; et al. "Repeated transplantation of mesenchymal stromal cells in Machado-Joseph disease/Spinocerebellar ataxia type-3 mice can sustainably alleviate phenotypic symptoms. . EUROPEAN JOURNAL OF CLINICAL INVESTIGATION". 2018.
    Publicado
  17. Duarte-Neves, Joana; Cunha-Santos, Janete; Gonçalves, Nélio; Simões, Ana Teresa Antunes; den Dunnen, Wilfred F.A.; Hirai, Hirokazu; Kügler, Sebastian; Pereira de Almeida, Luis Fernando Morgado; Cavadas, Claudia. "Neuropeptide Y alleviates Machado¿Joseph disease". Trabalho apresentado em Advances in NPY Research, 2016.
    Publicado • 10.1016/j.npep.2015.11.013
  18. Nobre, Rui Jorge; Saraiva, Joana; Fusco, Clelia; Paixão, Susana; Santana, Magda M; Sena-Esteves, Miguel; Pereira de Almeida, Luis Fernando Morgado. "Non-invasive AAV9-mediated silencing of mutant ataxin-3 alleviates motor and neuropathological deficits in a transgenic mouse model of Machado-Joseph disease, Human Gene Therapy". 2016.
    Publicado
  19. Gonçalves, Nélio; Simões, Ana Teresa Antunes; Cunha, Rodrigo A.; Pereira de Almeida, Luis Fernando Morgado. "Blockade of adenosine receptors by caffeine provides neuroprotection in a lentiviral mouse model of Machado-Joseph disease". Trabalho apresentado em 11th Meeting of the Portuguese Society for Neuroscience, Braga, 2009.
    Publicado • 10.3389/conf.neuro.01.2009.11.105
Tese / Dissertação
  1. Barros, Maria Inês Veiga de Almeida. "Assessing the putative role of mesenchymal stromal cells’ effectors in Machado-Joseph disease". Mestrado, 2019. http://hdl.handle.net/10316/86421.

Propriedade Intelectual

Patente
  1. Alves Sandro; Cartier-lacave Nathalie; Pereira De Almeida Luis; Nobrega Clévio; Mendonça Liliana. 2019. "EXPRESSION VECTOR FOR CHOLESTEROL 24-HYDROLASE IN THERAPY OF POLYGLUTAMINE REPEAT SPINOCEREBELLAR ATAXIAS".
  2. Nobre, Rui Jorge; Pereira de Almeida, Luis Fernando Morgado; CALDEIRA MARTINS, Teresa Maria. 2013. "HUMAN PAPILLOMAVIRUS DETECTION KIT AND ASSAY".

Outros

Outra produção
  1. Stage-dependent biomarker changes in spinocerebellar ataxia type 3. Annals of Neurology. 2023. Faber, J.; Berger, M.; Carlo, W.; Hübener-Schmid, J.; Schaprian, T.; Santana, M.M.; Grobe-Einsler, M.; et al. http://www.scopus.com/inward/record.url?eid=2-s2.0-85159405018&partnerID=MN8TOARS.
    10.1101/2023.04.21.23287817
  2. Polyglutamine disorders preface. 2018. Nóbrega, Clévio; Almeida, Luís Pereira de. http://hdl.handle.net/10400.1/11962.
    10.1007/978-3-319-71779-1
  3. Striatal and nigral pathology in a lentiviral rat model of Machado-Joseph disease. Machado-Joseph disease (MJD) is a fatal, dominant neurodegenerative disorder. MJD results from polyglutamine repeat expansion in the MJD-1 gene, conferring a toxic gain of function to the ataxin-3 protein. In this study, we aimed at overexpressing ataxin-3 in the rat brain using lentiviral vectors (LV), to generate an in vivo MJD genetic model and, to study the disorder in defined brain regions: s. 2008. Alves, Sandro; Régulier, Etienne; Nascimento-Ferreira, Isabel; Hassig, Raymonde; Dufour, Noelle; Koeppen, Arnulf; Carvalho, Ana Luísa; et al. http://hdl.handle.net/10316/12710.
Atividades

Apresentação oral de trabalho

Título da apresentação Nome do evento
Anfitrião (Local do evento)
2024/02 Gene therapy for Brain disorders: the case of Machado-Joseph disease. The 14th International Symposium of Gunma University Initiative for Advanced Research (GIAR) - Gene Therapy for Brain Diseases
Gunma University Showa - GIAR Viral Vector (Showa-machi Maebashi, Gunma, Japão)
2023/11 Gene therapy: new advances and future challenges. Targeting molecular mechanisms underlying neurodegeneration: focus on advanced therapies
ESN-ISN Neurochemistry School (Faro, Algarve, Portugal)
2023/10 Generating induced pluripotent stem cell-derived cerebellar neuronal progenitors for cell transplantation in Machado-Joseph Disease ETRS & SPCE-TC 2023 Joint Annual Meeting
(Coimbra, Portugal)
2023/03 Understanding the Mechanisms of Blood-Brain Barrier Dysregulation in Machado-Joseph Disease. Congresso Anual SPDMov 2023
2023/02 Cerebellar Neuronal Pregenitors for cerebellar transplantation in Machado-Joseph Disease 53rd Meeting of the Portuguese Society of Pharmacology, 41st Meeting of Clinical Pharmacology and 22nd Meeting of Toxicology
Portuguese Society of Pharmacology (Portugal)
2023/02 Pharmacological modulation of migration and neuronal differentiation of IPSC-derived neuroepithelial stem cells. 53rd Meeting of the Portuguese Society of Pharmacology, 41st Meeting of Clinical Pharmacology and 22nd Meeting of Toxicology
Portuguese Society of Pharmacology
2023/02 Mesenchymal Stromal Cells Alleviate Autophagy and Mitochondria Dynamics Alterations in Machado-Joseph Disease Models. 53rd Meeting of the Portuguese Society of Pharmacology, 41st Meeting of Clinical Pharmacology and 22nd Meeting of Toxicology
Portuguese Society of Pharmacology (Coimbra, Portugal)
2023/02 Investigating the clock components and circadian activity in the YAC-MJD mouse model. 53rd Meeting of the Portuguese Society of Pharmacology, 41st Meeting of Clinical Pharmacology and 22nd Meeting of Toxicology
Portuguese Society of Pharmacology (Coimbra, Portugal)
2023/02 Plasma-derived extracellular vesicles from Machado-Joseph Disease/Spinocerebellar Ataxia type 3 ataxic patients are enriched in mitochondrial, nuclear and nucleolar small RNA species. 53rd Meeting of the Portuguese Society of Pharmacology, 41st Meeting of Clinical Pharmacology and 22nd Meeting of Toxicology
Portuguese Society of Pharmacology (Coimbra, Portugal)
2023 Isolation of natural and biologically active EV-AAVs for brain gene delivery. 26th Annual Meeting of the American Society of Gene and Cell Therapy
American Society of Gene and Cell Therapy (Los Angeles (CA), Estados Unidos)
2023 Let's make a puzzle: unravelling how Mesenchymal Stromal Cells decrease mutant ataxin-3 levels and promote ameliorations in Machado-Joseph Disease? DCV.talks – Departamento das Ciências e da Vida (DCV)
Departamento das Ciências e da Vida (DCV) (Coimbra, Portugal)
2023 Induction of mutant atxin-3 uptake, and late autophagy and mitophagy improvements may contribute to reduction of mutant ataxin-3 levels in Spinocerebellar Ataxia Type-3 models. FENS Regional Meeting
(Algarve, Portugal)
2023 Extracellular vesicles-mediated delivery of CRISPR/Cas9 systems to treat Machado-Joseph Disease. (Paper presentation) 2023 CAG Triplet Repeat Disorder -Gordon Research Conference
Gordon Research
2022/12 Mesenchymal Stem Cells for Brain Disorders: the Particular case of Machado-Joseph Disease. Gene and Cell Therapy Curricular Unit from the Biomedical Sciences Graduation - Online Event
Biomedical Sciences Graduation - Algarve University (Algarve, Portugal)
2022/11 Intranasal delivery of Extracellular Vesicles carrying silencing sequences alleviates Spinocerebellar Ataxia Type 3 (SCA3). International Congress for Ataxia Research (ICAR)
(Dallas, Texas, Estados Unidos)
2022/10 MicroRNAs at the cornerstone of Machado-Joseph Disease pathogenesis: Leveraging disease-associated miRNA dysregulation to develop microRNA-based therapeutics. 4th meeting of the CIBB thematic area "Innovative Therapies"
CIBB (Coimbra, Portugal)
2022/10 Therapeutic strategies for spinocerebellar ataxia type 3. 32nd Annual NECTAR Meeting 2022
European Network for CNS transplantation. American School of Classical Studies in Athens - Cotsen Hall (Athens, Grécia)
2022/07 Extracellular communication in the brain through functional transfer of CRE ExRNA. Extracellular Vesicles Gordon Research Seminar & Conference
(Maine, Estados Unidos)
2022/06 Extracellular Vesicles packaging and delivery of silencing sequences to alleviate a brain disorder 27th European Society for Animal Cell Technology (27th ESACT)
European Society for Animal Cell Technology (Lisbon, Portugal)
2022/06 Gene Therapy: from gene addition to gene editing World Health Summit - Regional Meeting
World Health Summit (Rome, Itália)
2022/05 Optimal recovery of brain-derived extracellular vesicles 28th Porto Cancer Meeting
(Porto, Portugal)
2022/05 Extracellular Vesicles carrying silencing sequences alleviate Machado-Joseph Disease. International Society for Extracellular Vesicles (ISEV2022)
International Society for Extracellular Vesicles (Lyon, França)
2022/05 Extracellular communication in the brain through functional transfer of Cre ExRNA. Porto Cancer Meeting (PCM2022)
(Porto, Portugal)
2022/05 Spinocerebellar ataxia type 3: from mechanism to therapy. Sheffield Institute for Translational Neuroscience (SITraN) and our newly established Gene Therapy Innovation and Manufacturing Centre (GTIMC)
Sheffield Institute for Translational Neuroscience (SITraN) (Sheffield, Reino Unido)
2022/04 Non-invasive delivery of the brain-targeting AAV-PHP.eB encoding the cholesterol hydroxylase CYP46A1 into a mouse model of Spinocerebellar Ataxia type 3: a promising therapeutic strategy. SPDMov 2022
(Luso, Portugal)
2022/02 Reverting dysregulation of microRNA levels as a promising therapeutic strategy for Machado-Joseph Disease 52ª reunião da Sociedade Portuguesa de Farmacologia - SPF 2022
Sociedade Portuguesa de Farmacologia (Porto, Portugal)
2022/02 Induced Pluripotent Stem cells derived from Machado-Joseph Disease patients as a promising model to investigate microRNA dysregulation. 52ª reunião da Sociedade Portuguesa de Farmacologia - SPF 2022
Sociedade Portuguesa de Farmacologia (Porto)
2022/02 Assessing The Potential of Mesenchymal Stromal Cells For Alleviation Of Blood-Brain Barrier Dysfunction In Machado-Joseph Disease 52ª Reunião da Sociedade Portuguesa de Farmacologia (SPF)
Sociedade Portuguesa de Farmacologia (Porto, Portugal)
2022/02 Validation of the brain-targeting AAV- PHPeB enconding cholesterol hydroxylase CYP46A1 as a therapeutic candidate for Spinocerebellar Ataxia Type-3. 52ª Reunião da Sociedade Portuguesa de Farmacologia (SPF)
Sociedade Portuguesa de Farmacologia (Porto, Portugal)
2022/02 Non-pathogenic viral vectors pseudotyped with the SARS-CoV-2 S protein to study drug repurposing and immunization Strategies. 52ª Reunião da Sociedade Portuguesa de Farmacologia (SPF)
Sociedade Portuguesa de Farmacologia (Porto, Portugal)
2022/02 Extracellular vesicles-mediated delivery of CRISPR/Cas9 systems for therapeutic genome editing. 52ª Reunião da Sociedade Portuguesa de Farmacologia (SPF)
Sociedade Portuguesa de Farmacologia (Porto, Portugal)
2022/02 Intranasal delivery of Extracellular Vesicles carrying silencing sequences alleviates Machado-Joseph Disease (MJD). 52ª Reunião da Sociedade Portuguesa de Farmacologia (SPF)
Sociedade Portuguesa de Farmacologia (Porto, Portugal)
2022/02 Correction of ATXN3-CAG expansion in MJD patient-derived iPSC by CRISPR/Cas9 homology-directed repair. 52ª Reunião da Sociedade Portuguesa de Farmacologia (SPF)
Sociedade Portuguesa de Farmacologia (Porto, Portugal)
2022/01 Extracellular Vesicles carrying engineered miRNAs alleviate Machado-Joseph Disease (MJD). Programme in Experimental Biology and Biomedicine (BEB day)
(Coimbra, Portugal)
2022 Modelling Machado-Joseph Disease in patient-derived isogenic lines by CRISPR/Cas9 homology directed repair 26th Annual Portuguese Society of Human Genetics Meeting
Portuguese Society of Human Genetics (Coimbra, Portugal)
2022 Engineered nucleases targeting the ATXN3 gene for the therapy of Machado-Joseph disease. Flash Talk Presentation 27th European Society for Animal Cell Technology Meeting (ESACT2022)
European Society for Animal Cell Technology (Lisbon, Portugal)
2021/12 Non-pathogenic viral vectors pseudotyped with the SARS-CoV-2 S protein to study drug repurposing and immunization strategies. CIBB Annual Meeting
CIBB (Coimbra, Portugal)
2021/09 Extracellular vesicles: a promising delivery system for silencing sequences to treat Machado-Joseph Disease. PNEV Meeting 2021
I3S (Porto, Portugal)
2021/09 Extracellular communication mediated by EVs in mouse brain. PNEV Meeting 2021
I3S (Porto, Portugal)
2021/07 Endogenous striatum derived EVs distribution within the mouse brain. Virtual conference SNEV2021
2021/07 Biomarkers for Machado-Joseph Disease: microRNAs in plasma-derived extracellular vesicles as potential candidates. Student Network on Extracellular Vesicles International Online Conference
2021/07 Gene therapy for Brain disorders: the case of Machado-Joseph disease. II International Meeting of the Portuguese Society of Genetics
Portuguese Society of Genetics
2021/06 Blood-brain barrier (BBB) disruption is a shared feature for several neurodegenerative diseases. 55TH ANNUAL SCIENTIFIC MEETING OF the European Society of Clinical Investigation (ESCI) – Online Event
European Society of Clinical Investigation (ESCI)
2021/05 Outreach of striatum derived EVs in the mouse brain Virtual conference ISEV2021
2021/05 Gene therapy for CNS using AAVs: a perspective from the Portuguese research. Committee of Advanced Therapies (CAT) meeting
Committee for Human Medicinal Products (CHMP)
2021/02 iPSC-derived neuroepithelial stem cells depleted for mutant ataxin-3 for Machado-Joseph disease treatment. LI Annual meeting of the Portuguese Pharmacology Society, XXXIX Clinical Pharmacology meeting and XX meeting of Toxicology
Portuguese Society of Pharmacology (Portugal)
2021/02 Unravelling dysregulated micrornas in a transgenic mouse model of Machado-Joseph disease. 51.ª Reunião da Sociedade Portuguesa de Farmacologia, 39.ª Reunião de Farmacologia Clínica e 20ª Reunião de Toxicologia
Sociedade Portuguesa de Farmacologia (Lisbon, Portugal)
2021/02 Identification of dysregulated mirnas in human induced pluripotent stem cell-based models of Machado-Joseph disease: one step closer to a therapeutic approach? 51.ª Reunião da Sociedade Portuguesa de Farmacologia, 39.ª Reunião de Farmacologia Clínica e 20ª Reunião de Toxicologia
Sociedade Portuguesa de Farmacologia (Lisbon, Portugal)
2021/02 Importin-8 Silencing Prevents Mutant Ataxin-3 Aggregation And Delays Machado-Joseph Disease Progression. 51.ª Reunião da Sociedade Portuguesa de Farmacologia, 39.ª Reunião de Farmacologia Clínica e 20ª Reunião de Toxicologia
Sociedade Portuguesa de Farmacologia (Lisbon, Portugal)
2021/02 Brain microRNAs in plasma-derived extracellular vesicles as potential biomarkers for Machado-Joseph Disease 51.ª Reunião da Sociedade Portuguesa de Farmacologia, 39.ª Reunião de Farmacologia Clínica e 20ª Reunião de Toxicologia
Sociedade Portuguesa de Farmacologia (Lisbon, Portugal)
2021/02 Allele-specific silencing of Machado-Joseph disease using antisense oligonucleotide therapeutics 51.ª Reunião da Sociedade Portuguesa de Farmacologia, 39.ª Reunião de Farmacologia Clínica e 20ª Reunião de Toxicologia
Sociedade Portuguesa de Farmacologia (Lisbon, Portugal)
2021/02 Phenotypic characterization of a relevant model of Machado-Joseph disease: The YAC-MJD mouse model 51.ª Reunião da Sociedade Portuguesa de Farmacologia, 39.ª Reunião de Farmacologia Clínica e 20ª Reunião de Toxicologia
Sociedade Portuguesa de Farmacologia (Lisbon, Portugal)
2021 Extracellular vesicles- mediated delivery of CRISPR/Cas9 tools to treat Machado-Joseph Disease - Paper presentation 1st Meeting of the Portuguese Network on Extracellular Vesicles
2021 Phenotypic characterization of neuronal cultures derived from Machado-Joseph disease induced pluripotent stem cells 51.ª Reunião da Sociedade Portuguesa de Farmacologia, 39.ª Reunião de Farmacologia Clínica e 20ª Reunião de Toxicologia
Sociedade Portuguesa de Farmacologia (Lisbon, Portugal)
2020/11 Whole-Brain Biodistribution Analysis of Adeno-Associated Virus (AAV) with Single-Cell Resolution by Tissue Clearing and Light-Sheet Microscopy.
Virtual Early Career European Microscopy Congress 2020
2020/11 Whole-Brain Biodistribution Analysis of Adeno-Associated Virus (AAV) with Single-Cell Resolution by Tissue Clearing and Light-Sheet Microscopy. Virtual Early Career European Microscopy Congress 2020
2020/09 Predictors of quality of life in Machado-Joseph disease: a longitudinal observation study. The Movement Disorder Society Virtual Congress
2020/04 Blood-based biomarkers for Machado-Joseph disease: extracellular vesicles RNA profile & serum protein array. ESMI final meeting. Videoconference
ESMI
2020/03 Autophagy-lysosome pathway in neurodegenerative disease: the case of Machado-Joseph disease American Society of Experimental Neurotherapeutics Annual Meeting (ASENT)
American Society of Experimental Neurotherapeutics (ASENT) (Bethesda, Maryland, Estados Unidos)
2020/03 Preconditioning mice with osteosarcoma cells-derived secretome promote tumour cells engraftment and lung metastasis development. EACR-AACR-ASPIC Basic and Translational Research Conference – Tumor Microenvironment
EACR-AACR-ASPIC (Lisbon, Portugal)
2020/03 MSC Success in Promoting Ameliorations in Machado-Joseph Disease - Where do We Stand and Where We Should Go? Department of Life Sciences Seminars Series in Coimbra
Department of Life Sciences - Coimbra (Coimbra, Portugal)
2020/02/02 Establishment and characterization of human pluripotent stem cells derived brain organoids. L Annual meeting of the Portuguese Pharmacology Society, XXXVIII Clinical Pharmacology meeting and XIX meeting of Toxicology
Portuguese Society of Pharmacology (Portugal)
2020/02 Human IPSC-derived neuroepithelial stem cells for cell-based therapy in Machado-Joseph Disease. L Annual meeting of the Portuguese Pharmacology Society, XXXVIII Clinical Pharmacology meeting and XIX meeting of Toxicology
Portuguese Society of Pharmacology (Portugal)
2020/02 CRISPR-mediated silencing of mutant ataxin-3 ameliorates motor symptoms of a Machado-Joseph disease model in vivo. L Meeting of the Portuguese Society of Pharmacology (SPF)
Portuguese Society of Pharmacology (Coimbra, Portugal)
2020/02 Proteomic identification of a set of serum proteins with potential to be used as biomarkers for Machado-Joseph Disease. L Annual Meeting of the Portuguese Society of Pharmacology
Portuguese Society of Pharmacology (Coimbra, Portugal)
2020/02 Extracellular Vesicles for treatment of Machado-Joseph Disease. L Annual meeting of the Portuguese Pharmacology Society, XXXVIII Clinical Pharmacology meeting and XIX meeting of Toxicology
Portuguese Society of Pharmacology (Coimbra, Portugal)
2020 Permanent Inactivation of the ATXN3 Gene: A Possible Therapeutic Approach for Machado-Joseph Disease. 24th Annual meeting of the Portuguese Society of Human Genetics (SPGH 2020). Virtual meeting
Portuguese Society of Human Genetics (Portugal)
2019/12 MSC Success in Promoting Ameliorations in Machado-Joseph Disease - Where do We Stand and Where We Should Go? Center for Innovative Biomedicine and Biotechnology (CIIB) Meeting
(Coimbra, Portugal)
2019/11 Genetic Therapies for MJD International MJD Research Conference
(Washington, dc, USA, Estados Unidos)
2019/11 Whole-Brain Analysis of Adeno-Associated Virus (AAV) Biodistribution with Single-Cell Resolution by Tissue Clearing and Light-Sheet Microscopy. 2019 Spanish & Portuguese Advanced Optical Microscopy Meeting (SPAOM 2019)
(Coimbra, Portugal)
2019/11 A New Clearing Method for Whole-Brain Imaging with Single-Cell Resolution - Invited speaker at workshop 2019 Spanish & Portuguese Advanced Optical Microscopy Meeting (SPAOM 2019)
(Coimbra, Portugal)
2019/11 Reinstating levels of dysregulated autophagy-associated transcripts alleviates neuropathology and motor impairments of mouse models of Machado-Joseph disease. 2019 International Machado-Joseph Research Disease Conference
(Washington, DC, Estados Unidos)
2019/11 Reinstating levels of dysregulated autophagy-associated transcripts alleviates neuropathology and motor impairments of mouse models of Machado-Joseph disease. International Research Ataxia Conference (IARC) 2019
(Washington, DC, Estados Unidos)
2019/11 Blood-brain barrier dysfunction as a neuropathological feature in Machado-Joseph Disease. 1st Annual Meeting in Pharmaceutical Sciences
Pharmacy Faculty of UC (Coimbra, Portugal)
2019/11 Assessing the putative role of mesenchymal stromal cells’ effectors in Machado-Joseph disease. 1st Annual Meeting in Pharmaceutical Sciences
Pharmacy Faculty of UC (Coimbra, Portugal)
2019/11 CRISPR-Cas9 systems targeting ATXN3 as therapeutic approaches for Machado-Joseph Disease. Flash Talk Presentation. International Ataxia Research Conference (IARC 2019)
(Washington, DC, Estados Unidos)
2019/11 CRISPR-Cas9 systems targeting ATXN3 as therapeutic approaches for Machado-Joseph Disease. 2019 International Machado-Joseph Research Disease Conference
(Washington, DC, Estados Unidos)
2019/11 miRNA expression profile of plasma-derived extracellular vesicles distinguishes Machado-Joseph Disease patients from controls. 23rd Annual Meeting of the Portuguese Society of Human Genetics
Portuguese Society of Human Genetics
2019/11 Machado-Joseph Disease: the role of ageing in polyglutamine-induced neurodegeneration. 1st Annual Meeting in Pharmaceutical Sciences
Pharmacy Faculty of UC (Coimbra, Portugal)
2019/11 Extracellular vesicles-associated AAVs as gene delivery vectors for the treatment of brain diseases. (Flash poster presentation) 5th GEIVEX Symposium
(Granada, Espanha)
2019/11 Extracellular vesicles-associated AAVs as gene delivery vectors for the treatment of brain disorders. 1st Annual Meeting in Pharmaceutical Sciences
Pharmacy Faculty of UC (Coimbra, Portugal)
2019/10 Whole-Brain Analysis of Adeno-Associated Virus (AAV) Biodistribution with Single-Cell Resolution by Tissue Clearing and Light-Sheet Microscopy - Flash Talk Presentation EMBO | EMBL Symposium: Seeing Is Believing – Imaging the Molecular Processes of Life
EMBO | EMBL (Heidelberg, Alemanha)
2019/10 Spectroscopic Biomarkers as a Way of Monitoring MSC Success in Promoting Neuropathological and Phenotypic Ameliorations in Machado-Joseph Disease Models. 11th International Meeting of the Portuguese Society for Stem Cells and Cell Therapies (SPCE-TC)
Portuguese Society for Stem Cells and Cell Therapies (SPCE-TC) (Lisbon, Portugal)
2019/06 Machado Joseph disease animal models. Session Understanding human disease through animal models European Human Genetics Conference
European Human Genetics (Gothenburg, Sweden, Suécia)
2019/06 Generation and characterization of advanced models of SCA-3: patients-derived iPSCs cells. 4ª reunião anual do consórcio europeu JPND-Model PolyQ
Consórcio europeu JPND-Model PolyQ (Roma, Itália)
2019/05 Blood-brain barrier dysfunction as a neuropathological feature in Machado-Joseph Disease: Results from mouse and human brain tissues. XVI Meeting of the Portuguese Society for Neuroscience (SPN2019)
Portuguese Society for Neuroscience (Lisbon, Portugal)
2019/05 Sustainable phenotypic ameliorations in Machado-Joseph Disease/Spinocerebelar ataxia type-3 can be reached by repeated systemic administrations of mesenchymal stromal cells – and can be monitored through proton Magnetic Resonance Spectroscopy biomarkers. XVI Meeting of the Portuguese Society for Neuroscience (SPN2019)
Portuguese Society for Neuroscience (Lisbon, Portugal)
2019/05 Repeated transplantation of mesenchymal stromal cells in Machado-Joseph Disease/Spinocerebelar ataxia type-3 can sustainably alleviate phenotypic symptoms and ameliorations can be monitored through magnetic resonance spectroscopy. 53rd Annual Scientific Meeting of the European Society for Clinical Investigation (ESCI)
European Society for Clinical Investigation (ESCI) (Coimbra, Portugal)
2019/05 CRISPR interference-mediated silencing of mutant ATXN3 decreases motor impairments of an in vivo Machado-Joseph disease model. 53rd Annual Scientific Meeting of the European Society for Clinical Investigation (ESCI)
European Society for Clinical Investigation (ESCI) (Coimbra, Portugal)
2019/05 Permanent inactivation of the ATXN3 gene: A possible therapeutic approach for Machado-Joseph disease. XVI Meeting of the Portuguese Society for Neuroscience (SPN2019)
Portuguese Society for Neuroscience (Lisbon, Portugal)
2019/05 Characterization and follow-up of the Coimbra cohort of Machado-Joseph Disease Patients. 53rd Annual Scientific Meeting of the European Society for Clinical Investigation (ESCI)
European Society for Clinical Investigation (ESCI) (Coimbra, Portugal)
2019/05 Intersection of autophagy and exosome secretion on alpha-synuclein spreading pattern in in vitro models of Parkinson's disease 53rd Annual Scientific Meeting of the European Society for Clinical Investigation (ESCI)
European Society for Clinical Investigation (ESCI) (Coimbra, Portugal)
2019/02 Characterization of a trial-ready cohort of Machado-Joseph disease patients: status update. XLIX Reunião da Sociedade Portuguesa de Farmacologia, XXXVII Reunião de Farmacologia clínica, XVIII Reunião de toxicologia
Sociedade Portuguesa de Farmacologia (Porto, Portugal)
2019/02 Extracellular Vesicles-associated AAVs as gene delivery vectors for the treatment of brain diseases. XLIX Reunião da Sociedade Portuguesa de Farmacologia, XXXVII Reunião de Farmacologia clínica, XVIII Reunião de toxicologia
Sociedade Portuguesa de Farmacologia (Porto, Portugal)
2019/02 HUMAN IPSC-DERIVED NEUROEPITHELIAL STEM CELLS FOR NEUROPROTECTION AND NEUROREGENERATION IN MACHADO-JOSEPH DISEASE. XLIX Reunião da Sociedade Portuguesa de Farmacologia, XXXVII Reunião de Farmacologia clínica, XVIII Reunião de toxicologia
Sociedade Portuguesa de Farmacologia (Porto, Portugal)
2019/02 EXOSOMES AS A DELIVERY SYSTEM FOR MIRNAS IN MACHADO-JOSEPH DISEASE. XLIX Reunião da Sociedade Portuguesa de Farmacologia, XXXVII Reunião de Farmacologia clínica, XVIII Reunião de toxicologia
Sociedade Portuguesa de Farmacologia (Porto, Portugal)
2019/02 SIRTUIN 2 DEFICIENCY TRIGGERS HEPATIC LIPID ACCUMULATION THROUGH ER STRESS-DEPENDENT PATHWAY. XLIX Reunião da Sociedade Portuguesa de Farmacologia, XXXVII Reunião de Farmacologia clínica, XVIII Reunião de toxicologia
Sociedade Portuguesa de Farmacologia (Porto, Portugal)
2019/02 CYP46A1 OVEREXPRESSION ALLEVIATES MACHADO-JOSEPH DISEASE XLIX Reunião da Sociedade Portuguesa de Farmacologia, XXXVII Reunião de Farmacologia clínica, XVIII Reunião de toxicologia
Sociedade Portuguesa de Farmacologia (Porto, Portugal)
2019/02 MUTANT ATAXIN-3 SPREADING IN MACHADO-JOSEPH DISEASE. XLIX Reunião da Sociedade portuguesa de Farmacologia; XXXVII Reunião de Farmacologia Clínica; XVIII Reunião de Toxicologia
Sociedade Portuguesa de Farmacologia (Porto, Portugal)
2019/02 CHARACTERIZATION OF A TRIAL-READY PORTUGUESE COHORT OF MACHADO-JOSEPH DISEASE PATIENTS: STATUS UPDATE XLIX Reunião da Sociedade Portuguesa de Farmacologia, XXXVII Reunião de Farmacologia clínica, XVIII Reunião de toxicologia
Sociedade Portuguesa de Farmacologia (Porto, Portugal)
2019 Disruption of Blood-Brain Barrier in Machado-Joseph Disease. XLIX Reunião da Sociedade Portuguesa de Farmacologia, XXXVII Reunião de Farmacologia clínica, XVIII Reunião de toxicologia
Sociedade Portuguesa de Farmacologia (Porto, Portugal)
2019 A miRNA-based gene therapy approach to knock-down mutant ATXN3: Alleviation of Machado-Joseph disease phenotype in two mouse models upon two routes of administration. 53rd Annual Scientific Meeting of the European Society for Clinical Investigation (ESCI)
European Society for Clinical Investigation (ESCI) (Coimbra, Portugal)
2019 Autophagy Activation Induced By Let-7 Microrna Overexpression Counteracts Disease Phenotype In Machado-Joseph Disease Mouse Models. XVI Meeting of the Portuguese Society for Neuroscience (SPN2019)
Portuguese Society for Neuroscience (Lisbon, Portugal)
2018/12 Terapia Génica: os medicamentos do futuro
Rotary Club de Coimbra (Coimbra, Portugal)
2018/10 Non-invasive allele-specific silencing therapy and biomarkers for Machado-Joseph disease Conference on Changing the Face of Modern Medicine - Stem Cell and Gene Therapy European Soc Gene & Cell Therapy
Int Soc Stem Cell Res; French Soc Gene & Cell Therapy (Lausanne, Suiça)
2018/10 Patient-specific iPSC-derived neuroepithelial stem cells for neuroprotection and neuroregeneration in Machado-Joseph disease.
10th International Symposium on Neuroprotection and Neurorepair (Dresden, Alemanha)
2018/09 Em que ponto estamos na investigação da doença de Machado-Joseph ?
APAHE (Chamusca, Portugal)
2018/09 Vectores para Terapia Personalizada. Seminário Seat & Seed
Centro Hospitalar Universitário de Coimbra CHUC (Coimbra, Portugal)
2018/07 Non-invasive and allele-specific gene silencing therapy for Machado-Joseph disease. 18th World Congress of Basic and Clinical Pharmacology (WCP2018)
(Kyoto, Japão)
2018/07 Editing ATXN3 CAG repeat region using CRISPR-Cas9. 3nd JPND ModelPolyQ Meeting
JPND
2018/07 Generation and characterization of advanced models of SCA-3 patients-derived iPSCs cells and animal approaches. 3nd JPND ModelPolyQ Meeting
2018/07 Neuropeptide Y rescues aging phenotype of human Hutchinson-Gilford Progeria syndrome fibroblasts. 18th World Congress of Basic and Clinical Pharmacology (WCP2018)
(Kyoto, Japão)
2018/06 Neurodegenerative diseases: From common mechanisms to promising therapies. Workshop on Integrative approaches in Neurodegeneration
JPND programme - Faculty of Sciences University of Lisbon ( Lisbon, Portugal , Portugal)
2018/05 Non-invasive brain delivery of hybrid extracellular vesicles for therapy of Machado-Joseph Disease (MJD). Annual Meeting ISEV2018
(Barcelona, Espanha)
2018/02 From autophagy modulation to extracellular vesicles secretion in Machado-Joseph disease. 1st Meeting on Vesicular Biology
(Coimbra, Portugal)
2018/02 Das causas da doença de Machado-Joseph ao seu tratamento. Workshop Doença de Machado-Joseph: do Laboratório para a sociedade.
Centro de Neurociências e Biologia Celular (Coimbra, Portugal)
2018/02 Protocol for the characterization of CAG tract and flanking polymorphisms in polyQ disorders: impact on the diagnosis and in the development of gene-based therapies. XLVIII Reunião Anual Da Sociedade Portuguesa De Farmacologia, XXXVI Reunião De Farmacologia Clínica, XV Reunião de Toxicologia
Sociedade Portuguesa de Farmacologia (Lisbon, Portugal)
2018/02 CRISPR-Cas9-mediated pre- transcriptional silencing of mutant ataxin-3. XLVIII Reunião Anual Da Sociedade Portuguesa De Farmacologia, XXXVI Reunião De Farmacologia Clínica, XV Reunião de Toxicologia
Sociedade Portuguesa de Farmacologia (Lisbon, Portugal)
2018/02 Repeated mesenchymal stromal cells treatment sustainably alleviates Machado-Joseph disease. XLVIII Reunião Anual Da Sociedade Portuguesa De Farmacologia, XXXVI Reunião De Farmacologia Clínica, XV Reunião de Toxicologia
Sociedade Portuguesa de Farmacologia
2018/02 Characterization of a trial-ready Portuguese cohort of Machado-Joseph disease patients. XLVIII Reunião Anual Da Sociedade Portuguesa De Farmacologia, XXXVI Reunião De Farmacologia Clínica, XV Reunião de Toxicologia
Sociedade Portuguesa de Farmacologia (Lisbon, Portugal)
2018/02 AAV-Based Tools For The Development Of Cellular And Animal Models Of Machado-Joseph Disease. XLVIII Reunião Anual Da Sociedade Portuguesa De Farmacologia, XXXVI Reunião De Farmacologia Clínica, XV Reunião de Toxicologia
Sociedade Portuguesa de Farmacologia (Lisbon, Portugal)
2018/02 Reinstating levels of dysregulated autophagy-associated transcripts alleviates neuropathology and motor impairments of mouse models of Machado-Joseph disease. XLVIII Reunião Anual Da Sociedade Portuguesa De Farmacologia, XXXVI Reunião De Farmacologia Clínica, XV Reunião de Toxicologia
Sociedade Portuguesa de Farmacologia (Lisbon, Portugal)
2018/02 Pharmacological targeting of AMPK signaling pathway as a therapeutic approach to polyglutamine diseases. XLVIII Reunião Anual Da Sociedade Portuguesa De Farmacologia, XXXVI Reunião De Farmacologia Clínica, XV Reunião de Toxicologia
Sociedade Portuguesa de Farmacologia (Lisbon, Portugal)
2018/02 Hybrid vesicles: a promising therapeutic approach for MJD. 1st Meeting on Vesicular Biology
(Coimbra, Portugal)
2018/02 Cerebrovascular and Blood-brain Barrier Impairments in Machado-Joseph Disease. XLVIII Reunião Anual Da Sociedade Portuguesa De Farmacologia, XXXVI Reunião De Farmacologia Clínica, XV Reunião de Toxicologia
Sociedade Portuguesa de Farmacologia (Lisbon, Portugal)
2018/02 Generation of a Machado-Joseph disease isogenic control induced pluripotent stem cell line. XLVIII Reunião Anual Da Sociedade Portuguesa De Farmacologia, XXXVI Reunião De Farmacologia Clínica, XV Reunião de Toxicologia
Sociedade Portuguesa de Farmacologia
2018/02 Ibuprofen decreases neuroinflammation and improves neuropathology and motor impairments in Machado-Joseph disease. XLVIII Reunião Anual Da Sociedade Portuguesa De Farmacologia, XXXVI Reunião De Farmacologia Clínica, XV Reunião de Toxicologia
Sociedade Portuguesa de Farmacologia (Lisbon, Portugal)
2018/01 Non-invasive gene therapy of the brain. XII Spanish-Portuguese Conference on Drug Delivery. Tailoring drug delivery systems to the patients’ needs
CRS Spanish-Portuguese Local Chapter (Coimbra, Portugal)
2018/01 Exosomes: tiny vesicles with great potential for MJD treatment. XII Spanish-Portuguese Conference on Controlled Drug Delivery - Tailoring drug delivery systems to the patients' needs
(Coimbra, Portugal)
2018 Machado-Joseph disease: from mechanism to emerging therapies First Dutch Scientific Ataxia Symposium
Dutch Ataxia Society (Groningen, Países Baixos)
2018 Tailoring gene editing strategies for the treatment of Machado-Joseph disease. Portuguese Society of Movement Disorders (SPDMov)
Portuguese Society of Movement Disorders (SPDMov) (Curia, Portugal)
2017/12 Gene therapy and gene editing: from promise to first successes. Rare diseases symposium,
Instituto Nacional de Saúde Doutor Ricardo Jorge (Lisboa, Portugal)
2017/11 Advanced models of polyglutamine disorders (HD, SCA3, SCA7). ModelPolyQ. EU Joint Programme on Neurodegenerative disease Research JPND. Intermediate Symposium
ModelPolyQ. EU Joint Programme on Neurodegenerative disease Research JPND (Hague, Países Baixos)
2017/11 From microRNAs to gene silencing in Machado-Joseph disease. Workshop Highlights on Neurogenetics: Machado Joseph disease, Spastic paraplegias and Muscular Dystrophies: pathophysiology and biomarkers
Hospitais de Clinicas, Porto Alegre, Rio Grande do Sul, Brasil (Porto Alegre, Rio Grande do Sul,, Brasil)
2017/10 Human iPSCs-derived NESCs for cerebellar transplantation in Machado-Joseph disease. 10th International Meeting of the Portuguese Society for Stem Cells and Cell Therapies (SPCE-TC)
Portuguese Society for Stem Cells and Cell Therapies (SPCE-TC) (Covilhã, Portugal)
2017/05 From neurobiology to future therapies of Machado-Joseph disease. Annual Meeting of the JPND ESMI project
JPND ESMI project (Coimbra, Portugal)
2017/05 Interplay between autophagy and alpha-synuclein spreading in in vitro models of Parkinson’s disease. SPDMov, New Challenges in the Diagnosis and Treatment of Movement Disorders
Portuguese Society of Movement Disorders (SPDMov) (Ofir - Esposende, Portugal)
2017/04 Universidade e Ciência, Investigação e Produção Científica. Semana Cultural da Universidade de Coimbra
(Coimbra, Portugal)
2017/03 Terapias na doença de Machado-Joseph: estado da investigação. DIA DAS DOENÇAS RARAS 2017: “Com a Investigação as Possibilidades são Ilimitadas”
(Ponta Delgada, Portugal)
2017/01 Genetic manipulation in models of Machado-Joseph disease. Neuroscience and Mental Health: a clinical and molecular perspective
(Portugal)
2016/12 From gene to therapeutic approaches in Machado-Joseph disease. 1st Meeting on Biomedical Research
CNC.IBILI (Coimbra, Portugal)
2016/11 Silencing Machado-Joseph disease Brain Without Borders Conference
(Coimbra, Portugal)
2016/11 Molecular approaches for Machado-Joseph disease.
SPGH Sociedade Portuguesa de Genética Humana (Coimbra, Portugal)
2016/09 Potenciais estratégias terapêuticas para impedir a progressão da Doença de Machado Joseph. Encontro Ibérico de Ataxias Hereditárias. Partilhar para conhecer melhor
Hospitais da Universidade de Coimbra. Apahe (Coimbra, Portugal)
2016/09 Genetic approaches to fight neurodegenerative diseases. Master Course for Systems Biomedicine - videoconference
LCSB - Luxembourg Centre for Systems Biomedicine (Luxembourg, Luxemburgo)
2016/06 From gene to therapy of Machado-Joseph disease. 45th Annual Meeting of the Brazilian Biochemistry and Molecular Biology Society (SBBq)
Brazilian Biochemistry and Molecular Biology Society (SBBq) (Natal, RN, Brasil)
2016/06 From gene silencing to caloric restriction in neurodegeneration.
LCSB - Luxembourg Centre for Systems Biomedicine, University of Luxembourg (Luxembourg, Luxemburgo)
2016/03 Molecular therapy approaches for Machado-Joseph disease. Machado-Joseph disease Symposium: Where do we stand? The 10th World Congress on Controversies in Neurology (CONy)
World Congress on Controversies in Neurology (CONy) (Lisbon, Portugal, Portugal)
2015/11 Molecular approaches to block or modify neurodegeneration in Machado-Joseph disease
Centre for Neuroscience, Indian Institute of Science (Bangalore, Índia)
2015/11 Gene and Stem Cell Therapies for Brain disorders: the case of Machado-Joseph disease. Congress in Health Sciences Research: Towards Innovation and Entrepreneurship - Trends in Endocrinology and Neurosciences
(Covilhã, Portugal)
2015/08 From gene therapy to autophagy activation as therapeutic strategies for Machado-Joseph disease. International Conference on Machado Joseph Disease (MJD)
(Cairns, Austrália)
2015/06 New models for study of nervous system disease mechanisms: human inducible pluripotent stem cells. Genetics of Intellectual Disability – an update
(Braga, Portugal)
2015/04 Molecular translational research in neurodegenerative diseases. Meeting of the Health Cluster Portugal
(Coimbra, Portugal)
2015/02 Machado-Joseph disease: from gene silencing to protein clearance. Final Meeting of the TreatPolyQ Industrial Training Network
TreatPolyQ Industrial Training Network (Coimbra, Portugal)
2014/11 Cerebellar Neural Stem Cells Transplantation in Machado-Joseph disease Presentation to the press at the Society for Neurosciences Meeting
Society for Neurosciences (Washington D.C, Estados Unidos)
2014/11 Terapia génica da Doença de Machado-Joseph. VIII Congresso Científico NEF/AAC- "Cérebro e (dis)funções"
(Coimbra, Portugal)
2014/10 Doença de Machado-Joseph: do mecanismo à terapia. 18º Encontro de Ataxias da ABAHE
Abahe - Associação Brasileira de Ataxias Hereditárias e Adquiridas (Taubaté, Brasil)
2014/10 Insights from Machado-Joseph disease transgenic mice may lead to new therapeutic approaches. Invited Seminar
Hospital de Clínicas de Porto Alegre, Univ. Fed. do Rio Grande do Sul (Porto Alegre, Rio Grande do Sul, Brasil)
2014/10 From mechanism to therapy of the polyglutamine Machado-Joseph Disease. Invited Seminar
University of Campinas (Campinas, Brasil)
2014/09 Pharmacological activation of autophagy to alleviate Machado-Joseph disease. Dia Nacional do Farmacêutico 2014 - Comemorações
Ordem dos Farmacêuticos (Coimbra, Portugal)
2014/05 From Mechanism to Therapy of the polyglutamine Machado-Joseph disease. Invited Seminar at Hebrew University of Jerusalem, Silberman building.
Hebrew University of Jerusalem (Jerusalem, Israel)
2014/04 Doença de Machado-Joseph: do mecanismo à terapia. 2nd  Annual Meeting of Coimbra Health School
(Coimbra, Portugal)
2014/02 Silencing Machado-Joseph disease. Gene-based Therapeutics for Neurological Disorders. From Basic Science to Clinical Applications, Fiesta Americana Condesa
Fiesta Americana Condesa (Cancun, México)
2014/01 Molecular therapy approaches for Machado-Joseph disease. Seminário UC Biotech
(Cantanhede, Portugal)
2013/10 Molecular approaches to modify Machado-Joseph disease progression. Invited Seminar at the University of Massachussets Medical School
University of Massachussets Medical School, Gene Therapy Center,Albert Sherman Center (Worcester, Estados Unidos)
2013/07 Viral vectors for gene therapy to the brain: from animal models to gene therapy. NEURASMUS Annual Meeting and Workshop
University of Coimbra (Coimbra, Portugal)
2013/06 Nanotechnology and nanomedicines in neurological research. EURECNET Conference: “Research in Neurosciences: Scientific, ethical and legal challenges for review by research ethics committees”
EURECNET (Lisbon, Portugal, Portugal)
2013/05 Towards the understanding of pathological protein processing and toxicity in Machado-Joseph disease. Meeting of the E-rare project, call 2012: European Research Projects on rare diseases driven by young investigators
European Research Projects on rare diseases driven by young investigators (Bonn, Alemanha)
2013/03 Silencing Machado-Joseph disease. IV Jornadas Nacionais de Ciências Biomédicas: Onde a Ciência move o futuro
(Aveiro, Portugal)
2013/02 Molecular therapy of Machado-Joseph disease. TreatPolyQ Mid-Term Meeting and Training
(Paris)
2013/01 Células Estaminais Pluripotentes Induzidas.
Escola Secundária D. Maria (Coimbra, Portugal)
2012/11 Targeted treatment for Machado-Joseph disease. 16ª Reunião Anual da Sociedade Portuguesa de Genética Humana
(Porto, Portugal)
2012/10 Machado-Joseph Disease: from models to progression blockage. Neurodegenerative diseases: From molecules to clinics and beyond
(Portugal)
2012/10 Allele-specific therapies: The case of Machado-Joseph disease. 2º Simpósio do Fórum de Pós-docs "Changing Paradigms of Science"
(Coimbra, Portugal)
2012/09 Do mecanismo à terapia da doença de Machado-Joseph disease. Dia Internacional das Ataxias
APAHE (Coimbra, Portugal)
2012/07 From mechanism to therapy of Machado-Joseph disease. Broad Institute; Cambridge
(Cambridge MA, Estados Unidos)
2012/04 Doenças neurodegenerativas: Mecanismos e novas abordagens terapêuticas. Palestra na Plural
(Coimbra, Portugal)
2012/03 Disease-modifying strategies for Machado-Joseph disease. Fourth Ataxia Investigators’ Meeting (AIM 2012), AIM 2012: Advancing Toward Therapeutics
National Ataxia Foundation NAF (Grand Hyatt San Antonio, San Antonio, Texas, Estados Unidos)
2012/03 Investigating disease-modifying strategies for Machado-Joseph disease. Patient Information session
(Los Altos, Estados Unidos)
2012/01 From mechanism to therapy of Machado-Joseph disease. iMM Monday Lecture
(Lisboa, Portugal)
2012 From mechanism to therapy of Machado-Joseph disease
University of Michigan, Department of Neurology (Ann Arbor, Michigan)
2012 From mechanism to therapy of neurodegenerative diseases: The case of Machado-Joseph disease. Workshop – Sinergias e Financiamento
Divisão de Apoio e Promoção de Investigação (DAPI) (Coimbra, Portugal)
2011/07 Modifying neurodegeneration in Machado-Joseph disease.
Carey Lab, Champalimaud Foundation (Lisboa, Portugal)
2011/06 Gene Therapy to the Central Nervous System.
(Coimbra, Portugal)
2011/02 Modifying neurodegeneration in Machado-Joseph disease.
(Lisboa, Portugal)
2011/01 Modifying neurodegeneration in Machado-Joseph disease.
(Lisboa, Portugal)
2010/11 Blocking neurodegeneration in Machado-Joseph disease. MIT Portugal Program - Visiting Scholar Lecture
Massachusetts Institute of Technology - MIT (Cambridge MA, Estados Unidos)
2010/11 Modifying neurodegeneration in Machado-Joseph disease.
Xandra Breakfield Group, Harvard Medical School (Charlestown; Boston , Estados Unidos)
2010/11 Modelling and modifying Machado-Joseph disease.
Kaspar Lab; Nationswide Children’s Hospital (Columbus, Ohio, Estados Unidos)
2010/10 Silencing Machado-Joseph disease.
Centre for BioNano Interactions, School of Chemistry & Chemical Biology University College Dublin (Belfield, Dublin, Irlanda)
2010/05 Silencing Machado-Joseph disease. ENINET Final Meeting
Network of European Neuroscience Institutions (Coimbra, Portugal)
2009/12 Effects of overexpression or silencing of neuropeptide Y in the rat hypothalamic arcuate nucleus achieved by viral vector approach in feeding behaviour. XL Reunião da Sociedade Portuguesa de Farmacologia
Sociedade Portuguesa de Farmacologia (Porto, Portugal)
2009/09 RNA interference for Machado-Joseph disease. Jornadas Cientificas Internationales de Euro-Ataxia.
(Valladolid, Espanha)
2009/06 RNA interference for the treatment of Machado-Joseph disease: the role of endogenous wild-type ataxin-3 11th meeting of the Portuguese Society for Neurosciences
Portuguese Society for Neurosciences (Braga, Portugal)
2009/04 Inhibition of calpains in a lentiviral mouse model of Machado-Joseph disease prevents nuclear localization of mutant ataxin-3 and reduces neuronal dysfunction and degeneration. V international Workshop on Machado-Joseph disease
(S. Miguel, Azores, Portugal)
2009/04 RNA interference for the treatment of Machado-Joseph disease: the role of endogenous wild-type ataxin-3. V international Workshop on Machado-Joseph disease
(S. Miguel, Azores, Portugal)
2009/04 Neuroprotective effects mediated by the autophagy-related protein BECLIN-1 in a lentiviral-based rat model of Machado-Joseph disease. V international Workshop on Machado-Joseph disease
(S. Miguel, Azores, Portugal)
2009/04 Gene transfer approach for the study of the adenosine A2A receptors role in Machado Joseph disease V international Workshop on Machado-Joseph disease
(S. Miguel, Azores, Portugal)
2009/04 Doenças neurodegenerativas e envelhecimento: o modelo da doença de Machado-Joseph. V Ciclo de Conferências do Instituto de Ciências da Saúde do Norte (ISCS-N)
(Porto, Portugal)
2009/04 Terapia celular e terapia génica do sistema nervoso central. XIV Simpósio NEF/AAC, Biotecnologia nas Ciências da Saúde
(Coimbra, Portugal)
2009/03 Human papillomavirus detection Kit. Healthcare Biotech Forum
(Rome, Itália)
2009/01 Human papillomavirus detection Kit. i-techpartner Growth Academy
i-techpartner Growth Academy (Coimbra, Portugal)
2008/12 Gene transfer approach for the study of the adenosine A2A receptors role in Machado-Joseph disease. VI Annual Meeting of CNC & Annual Meeting of the Doctoral Programme in Experimental Biology and Biomedicine
CNC- Centro de Neurociências e Biologia Celular da Universidade de Coimbra - Biocant Park (Cantanhede, Portugal)
2008/10 Silencing Neuropeptide Y in the CNS: the AAV-microRNA tool-kit. XVI Congress of Biochemistry
University of Azores (Ponta Delgada, Azores, Portugal)
2008/09 A lentiviral rat model of Machado-Joseph disease. Friday noon seminars
(Porto, Portugal)
2008/06 Diagnostic Kit for complete genital Human papillomavirus genotyping. The Medtech Forum
(Coimbra, Portugal)
2008/01 Diagnostic Kit for Genital Human Papillomavirus typing. Idea Spring 2008 – MIT program
MIT program - Biocant (Cantanhede, Portugal)
2008/01 Gene Therapy as a strategy of delivery to the Central Nervous System: from animal models of disease to therapies.
(Coimbra, Portugal)
2007/12 Complete genotyping of mucosal Human papillomavirus in Portuguese population using a novel PCR-RFLP methodology and an original algorithm. Encontro anual do Centro de Neurociências e Biologia Celular 2007
CNC- Centro de Neurociências e Biologia Celular da Universidade de Coimbra (Coimbra, Portugal)
2007/12 siRNA delivery to the Central Nervous System: Tf-lipoplex-mediated gene silencing in vitro and in vivo. V Encontro anual do Centro de Neurociências e Biologia Celular 2007
CNC- Centro de Neurociências e Biologia Celular da Universidade de Coimbra (Coimbra - Bencanta, Portugal)
2007/09 Viral vectors for gene transfer to the Central Nervous System: from animal models of disease to therapy.
(Lisboa, Portugal)
2007/07 Viral vectors for modeling polyglutamine disorders Novel Molecular Strategies to treat Neurodegenerative Diseases
PENS Summer School (Ofir - Esposende, Portugal)
2007/04 Viral vectors for gene transfer to the Central Nervous System. Encontro de Ciência em Portugal
(Lisboa, Portugal)
2006/12 Viral vectors for gene transfer to the Central Nervous System Neurological Diseases Research
Sanofi-Aventis (Vitry sur Seine, França)
2006/12 Modelling and gene silencing in Machado-Joseph disease. IV Encontro Anual do CNC
CNC- Centro de Neurociências e Biologia Celular da Universidade de Coimbra - Biocant (Cantanhede, Portugal)
2006/12 Gene silencing in the CNS: Tf-lipoplexes for neuronal siRNA delivery in vitro and in vivo. XV National Congress of Biochemistry
(Aveiro, Portugal)
2006/11 Novas tecnologias aplicadas ao medicamento experimental: Terapia Génica do sistema nervoso. Clinical Trial Management: Global Strategies for a Global World
Simpósio Núcleo de Estudantes de Farmácia (Coimbra, Portugal)
2006/05 Lentiviral vectors for gene therapy of neurodegenerative disorders. 1º ciclo de Simpósios da Sociedade Portuguesa de Ciências Farmacêuticas (SPCF)
(Lisboa, Portugal)
2006/04 siRNA delivery by Tf-associated lipoplexes: a novel non-viral strategy to mediate gene silencing in neurons. Congress of the German Pharmacological Society
German Pharmacological Society (Mainz, Alemanha)
2005/12 Cationic Liposome-mediated In Vivo Gene Transfer to the CNS. XIV National Congress of Biochemistry
(Vilamoura, Algarve, Portugal)
2005/12 Vectores virais para terapia Génica do sistema nervoso; Dos genes à inovação terapêutica.
Simpósio Núcleo de Estudantes de Farmácia (Coimbra, Portugal)
2004/06 Applications of Lentiviral Vectors in Polyglutamine disorders. Advanced methods for industrial production, purification and characterization of gene vectors
(Evry, França)
2004/02 Lentiviral vectors for gene silencing in polyglutamine disorders: Ataxin 3 gene silencing by lentiviral mediated delivery of double-stranded RNAs. 2nd European Conference and Practical Course on Pre-clinical Gene Transfer to Train Researchers on Gene Therapy
Facultat de Veterinària, Universitat Autònoma de Barcelona (UAB) (Barcelona, Espanha)
2002/09 A new lentiviral-based model of Huntington’s disease in rats Novel Therapeutic Opportunities in Neurodegenerative Disease
Universidade de Aveiro (Aveiro, Portugal)
2002/06 Lentiviral-based gene delivery approaches for therapeutic and functional studies in Huntington’s disease. Ciclo de Seminários do Centro de Neurociências
(Coimbra, Portugal)
2002/03 Gene Therapy for Neurodegenerative diseases: Lentiviral vectors in Huntington’s disease. Jornadas Albert Netter, Biotecnologia e Genética em Ginecologia
Sociedade Europeia de Ginecologia (Coimbra, Portugal)
2001/08 Progressive neuropathology in the striatum of rats injected with lentiviral vectors encoding various mutant huntingtin fragments. 19th International Meeting of the World Federation of Neurology Research Group on Huntington’s Disease
World Federation of Neurology Research Group on Huntington's Disease (Copenhagen, Dinamarca)
2001/08 Neuroprotective effect of interleukin-6 and IL6R chimera in the quinolinic acid rat model of Huntington’s disease. 19th International Meeting of the World Federation of Neurology Research Group on Huntington’s Disease
World Federation of Neurology Research Group on Huntington’s Disease (Copenhagen, Dinamarca)
2001/06 Lentiviral-mediated delivery of mutant huntingtin (Htt) in the striatum of rats induces a neuropathology modulated by polyglutamine repeat size, Htt expression levels and protein length. Gordon Conference on CAG triplet repeat disorders
Gordon-Mount Holyoke College (Estados Unidos)

Curso / Disciplina lecionado

Disciplina Curso (Tipo) Instituição / Organização
2018/12/13 - 2018/12/13 Terapia Génica: sucessos recentes e desafios futuros Mestrado integrado em Medicina Universidade de Coimbra Faculdade de Medicina, Portugal
2018/11/27 - 2018/11/27 Extracellular vesicles in brain disorders PhD Program in Health Sciences Universidade de Coimbra Faculdade de Medicina, Portugal
2018/11/17 - 2018/11/17 Machado-Joseph disease: from mechanism to emerging therapies Mestrado Farmacologia Aplicada Universidade de Coimbra Faculdade de Farmácia, Portugal

Universidade de Coimbra Centro de Neurociências e Biologia Celular, Portugal
2018/10/31 - 2018/10/31 Genetic approaches to fight neurodegenerative diseases Master/PhD in Neurosciences Universidade de Lisboa Instituto de Medicina Molecular João Lobo Antunes, Portugal

Universidade de Lisboa Faculdade de Medicina, Portugal
2018/09/17 - 2018/09/21 Gene Therapy: Viral vectors for molecular surgery Programa Doutoral da Faculdade de Farmácia de Lisboa Universidade de Lisboa Faculdade de Farmácia, Portugal
2018/07/12 - 2018/07/12 Gene Therapy: dawn of a new era. European Drug Regulation and Advanced Therapies Course Universidade do Porto Faculdade de Farmácia, Portugal
2018/05/28 - 2018/05/28 Gene Therapy to Brain Disorders. Principles and Practice in Drug Development. Curso Avançado no âmbito do Programa Doutoral em Bioengenharia do MIT-Portugal Massachusetts Institute of Technology MIT Portugal Program, Portugal
2018/05/07 - 2018/05/11 Gene Therapy Approaches. Programa Doutoral em Biologia Experimental e Biomedicina Universidade de Coimbra Centro de Neurociências e Biologia Celular, Portugal
2018/04/23 - 2018/04/27 Machado-Joseph disease: from models to reversibility. Programa Doutoral em Biologia Experimental e Biomedicina Universidade de Coimbra Centro de Neurociências e Biologia Celular, Portugal
2018/04/26 - 2018/04/26 Gene Therapy Approaches. Mestrado em Biologia Celular e Molecular Universidade de Coimbra Faculdade de Ciencias e Tecnologia, Portugal
2018/02/28 - 2018/02/28 Novel models and therapies in Machado-Joseph Programa Doutoral em Ciências da Saúde Universidade de Coimbra Faculdade de Medicina, Portugal
2018/02/28 - 2018/02/28 From microRNAs to gene silencing in Machado-Joseph disease. Programa Doutoral em Ciências da Saúde Universidade de Coimbra Faculdade de Medicina, Portugal
2017/12/11 - 2017/12/11 Extracellular vesicles in brain disorders. PhD Program in Health Sciences Universidade de Coimbra Faculdade de Medicina, Portugal
2017/12/05 - 2017/12/05 On the mechanism of Machado-Joseph disease. PhD Program in Health Sciences Universidade de Coimbra Faculdade de Medicina, Portugal
2017/11/08 - 2017/11/08 Gene Therapy to Brain Disorders Principles and Practice in Drug Development Massachusetts Institute of Technology, Estados Unidos
2017/10/31 - 2017/10/31 Gene therapy approaches to fight neurodegenerative diseases. Master/PhD in Neurosciences Universidade de Lisboa Instituto de Medicina Molecular João Lobo Antunes, Portugal

Universidade de Lisboa Faculdade de Medicina, Portugal
2017/09/25 - 2017/09/25 Gene therapy and applications in neurologic diseases. FCT PhD PROGRAM IN MEDICINES AND PHARMACEUTICAL INNOVATION (I3DU) Universidade de Lisboa Faculdade de Farmácia, Portugal
2017/07/07 - 2017/07/07 Viral and non-viral gene therapy approaches for neurodegenerative disease treatment. FCT PhD PROGRAM IN MEDICINES AND PHARMACEUTICAL INNOVATION (I3DU) Universidade de Lisboa Faculdade de Farmácia, Portugal
2017/03/25 - 2017/03/25 Translational Research in Machado Joseph disease. From Genotype to Phenotype. PhD Programme in Health Sciences Universidade de Coimbra Faculdade de Medicina, Portugal
2017/03/15 - 2017/03/15 Genetic approaches to fight neurodegenerative diseases. Mestrado em Biologia Celular e Molecular Universidade de Coimbra Faculdade de Ciencias e Tecnologia, Portugal
2016/11/22 - 2016/11/22 Stem Cells: from biology to Brain Repair and Disease Modelling. “Mecanismos Moleculares de Doença” Programa de Doutoramento em Ciencias da Saúde Universidade de Coimbra Faculdade de Medicina, Portugal
2016/11/12 - 2016/11/12 Da Investigação à terapia da doença de Machado-Joseph. Mestrado em Farmacologia Aplicada Universidade de Coimbra Faculdade de Farmácia, Portugal
2016/11/12 - 2016/11/12 Da Investigação à terapia da doença de Machado-Joseph. Mestrado em Farmacologia Aplicada Universidade de Coimbra Faculdade de Farmácia, Portugal
2016/10/12 - 2016/10/12 Advanced Brain Therapies: the case of Machado-Joseph disease Principles and Practice in Drug Development Massachusetts Institute of Technology, Estados Unidos
2016/10/06 - 2016/10/06 Vetores virais para terapia génica. Programa Interuniversitário de Doutoramento em Envelhecimento e Doenças Crónicas; Programa de Doutoramento em Ciências da Saúde Universidade de Coimbra Faculdade de Medicina, Portugal
2016/06/15 - 2016/06/15 Advanced Therapies for Brain Disorders. Programa Doutoral em Biologia Experimental e Biomedicina Universidade de Coimbra Centro de Neurociências e Biologia Celular, Portugal
2016/05/23 - 2016/05/23 Silencing brain disease. Licenciaturas em Ciências Biomédicas, Bioquímica, Biologia, Biologia Marinha e Mestrado Integrado em Ciências Farmacêuticas Universidade do Algarve, Portugal
2016/04/14 - 2016/04/14 Advanced Therapies for Brain Disorders. MIT- Portugal Bioengineering Program
2016/04/04 - 2016/04/04 Viral vectors for gene therapy. Mestrado em Biologia Celular e Molecular Universidade de Coimbra Faculdade de Ciencias e Tecnologia, Portugal
2016/03/15 - 2016/03/15 Viral and non-viral gene therapy approaches for neurodegenerative disease treatment FCT PhD PROGRAM IN MEDICINES AND PHARMACEUTICAL INNOVATION (I3DU) Universidade de Lisboa Faculdade de Farmácia, Portugal
2015/11/14 - 2015/11/14 Doença de  Machado-Joseph: mecanismos fisiopatológicos e novas abordagens terapêuticas. Mestrado em Farmacologia Aplicada Universidade de Coimbra Faculdade de Farmácia, Portugal
2015/11/09 - 2015/11/09 Regulation of proteostasis in the brain. Programa de Doutoramento em Ciencias da Saúde Universidade de Coimbra Faculdade de Medicina, Portugal
2015/10/29 - 2015/10/29 Gene Therapy as a strategy of drug delivery to the Central Nervous System Principles and Practice in Drug Development Massachusetts Institute of Technology, Estados Unidos
2015/10/14 - 2015/10/14 Viral vectors for gene delivery : from disease modeling to therapy. Programa Interuniversitário de Doutoramento em Envelhecimento e Doenças Crónicas; Programa de Doutoramento em Ciências da Saúde Universidade de Coimbra Faculdade de Medicina, Portugal
2015/05/16 - 2015/05/16 Doença de  Machado-Joseph: mecanismos fisiopatológicos e novas abordagens terapêuticas. Mestrado em Farmacologia Aplicada Universidade de Coimbra Faculdade de Farmácia, Portugal
2015/04/29 - 2015/04/29 Machado-Joseph disease: from models to reversibility. Programa Doutoral em Biologia Experimental e Biomedicina Universidade de Coimbra Centro de Neurociências e Biologia Celular, Portugal
2015/04/15 - 2015/04/15 Advanced Therapies for the Central Nervous System: Gene and Stem cell therapies. Programa Doutoral em Biologia Experimental e Biomedicina Universidade de Coimbra Centro de Neurociências e Biologia Celular, Portugal
2015/03/23 - 2015/03/23 Viral vectors for gene therapy. Mestrado em Biologia Celular e Molecular Universidade de Coimbra Faculdade de Ciencias e Tecnologia, Portugal
2015/03/23 - 2015/03/23 Viral vectors for gene therapy. Mestrado em Biologia Celular e Molecular Universidade de Coimbra Faculdade de Ciencias e Tecnologia, Portugal
2014/12/04 - 2014/12/04 Genetic approaches to fight neurodegenerative diseases. PhD/Master in Neurosciences Universidade de Lisboa Instituto de Medicina Molecular João Lobo Antunes, Portugal
2014/10/27 - 2014/10/27 Translational Research in Machado-Joseph Disease. Programa de Doutoramento em Ciências da Saúde Universidade de Coimbra Faculdade de Medicina, Portugal
2014/10/13 - 2014/10/13 Viral vectors for gene delivery : from disease modeling to therapy. Programa Interuniversitário de Doutoramento em Envelhecimento e Doenças Crónicas; Programa de Doutoramento em Ciências da Saúde Universidade de Coimbra Faculdade de Medicina, Portugal
2014/04/09 - 2014/04/09 Gene Therapy as a strategy of drug delivery to the Central Nervous System. MIT-Portugal Bioengineering PhD Programme
2014/03/28 - 2014/03/28 Viral vectors for gene therapy. Mestrado em Biologia Celular e Molecular Universidade de Coimbra Faculdade de Ciencias e Tecnologia, Portugal
2014/01/20 - 2014/01/20 Machado-Joseph disease: from mechanism to disease-modifying therapies. Lisbon Biomed PhD Programme Universidade de Lisboa Instituto de Medicina Molecular João Lobo Antunes, Portugal
2014/01/16 - 2014/01/16 Viral vectors for gene delivery : from disease modeling to therapy. Programa Interuniversitário de Doutoramento em Envelhecimento e Doenças Crónicas; Programa de Doutoramento em Ciências da Saúde Universidade de Coimbra Faculdade de Medicina, Portugal
2013 - 2014 Challenging animal models of Machado-Joseph disease. PhD Programme in Health Sciences (PhDHS); Interuniversitary PhD Programme in Aging and Chronic Diseases (PhDOC) Universidade de Coimbra Faculdade de Medicina, Portugal
2013/12/03 - 2013/12/09 Gene transfer with viral vectors: from animal models to gene therapy Treat PolyQ training week: Generation and analysis of transgenic model organisms Universitaet Tuebingen Fachbibliothek Mathematik und Physik, Alemanha
2013/12/05 - 2013/12/05 Genetic approaches to fight neurodegenerative diseases. Mestrado/Doutoramento em Neurociências Universidade de Lisboa Instituto de Medicina Molecular João Lobo Antunes, Portugal
2013/11/19 - 2013/11/19 From Genotype to Phenotype -Translational Research in Machado Joseph Disease. Programa Doutoral em Biomedicina Universidade de Coimbra Faculdade de Medicina, Portugal
2013/10/16 - 2013/10/16 Gene Therapy as a strategy of drug delivery to the Central Nervous System Principles and Practice in Drug Development Massachusetts Institute of Technology, Estados Unidos
2013/05/03 - 2013/05/03 Doenças de Huntington e Machado-Joseph: Estratégias de terapia molecular. Mestrado em Farmacologia aplicada Universidade de Coimbra Faculdade de Farmácia, Portugal
2013/04/05 - 2013/04/05 Gene therapy for CNS Mestrado em Biologia Celular e Molecular Universidade de Coimbra Faculdade de Ciencias e Tecnologia, Portugal
2013/03/06 - 2013/03/06 Gene transfer with viral vectors: from animal models to gene therapy. Universidade do Porto Faculdade de Farmácia, Portugal
2013/02/20 - 2013/02/20 Crossing the blood-brain barrier with nucleic acids. Curso Avançado: Brain and ocular diseases: How to overcome the barriers? From basic science to imaging approaches? Universidade de Coimbra, Portugal
2013/01/29 - 2013/01/29 Gene Therapy as a strategy of drug delivery to the Central Nervous System. MIT-Portugal program
2013/01/07 - 2013/01/11 Gene transfer with viral vectors: from animal models to gene therapy. Doctoral Program in Experimental Biology and Biomedicine; Advanced Course "Gene and Cell therapy of CNS: from microRNAs to IPS cells and gene repair" Universidade de Coimbra Centro de Neurociências e Biologia Celular, Portugal
2012/12/12 - 2012/12/12 Genetic approaches to fight neurodegenerative diseases. Mestrado/Doutoramento em Neurociências Universidade de Lisboa Faculdade de Medicina, Portugal
2012/11/27 - 2012/11/27 From Genotype to Phenotype -Translational Research in Machado Joseph Disease. Programa Doutoral em Biomedicina Universidade de Coimbra Faculdade de Medicina, Portugal
2012/11/19 - 2012/11/23 Induced Pluripotent Stem Cells Doctoral Program in Health Sciences Universidade de Coimbra Faculdade de Medicina, Portugal
2012/10/23 - 2012/10/23 Vectors for Gene Therapy. Programa de doutoramento em ciências da saúde Universidade de Coimbra Faculdade de Medicina, Portugal
2012/10/18 - 2012/10/18 Gene Therapy as a strategy of drug delivery to the Central Nervous System Principles and Practice in Drug Development Massachusetts Institute of Technology, Estados Unidos
2012/10/13 - 2012/10/13 Vectores virais para terapia génica do sistema nervoso. Curso Biotecnologia: Terapias Avançadas IEC – Instituto de Educação e Cidadania, Portugal
2012/05/19 - 2012/05/19 Doenças de Huntington e Machado-Joseph: Estratégias de terapia molecular. Mestrado em Farmacologia aplicada Universidade de Coimbra Faculdade de Farmácia, Portugal
2012/04/12 - 2012/04/12 Viral vectors for gene therapy. Mestrado em Biologia Celular e Molecular
2012/04/12 - 2012/04/12 Gene therapy for CNS. Mestrado em Biologia Celular e Molecular Universidade de Coimbra Faculdade de Ciencias e Tecnologia, Portugal
2012/02/24 - 2012/02/24 Modifying Machado-Joseph disease. Doctoral Programme in Health Sciences Universidade de Coimbra Faculdade de Medicina, Portugal
2012/01/24 - 2012/01/24 Gene Therapy as a strategy of drug delivery to the Central Nervous System. MIT-Portugal program
2011/12/07 - 2011/12/07 Genetic approaches to fight neurodegenerative diseases. Mestrado/Doutoramento em Neurociências Universidade de Lisboa Faculdade de Medicina, Portugal
2011/11/17 - 2011/11/17 Gene Therapy as a strategy of drug delivery to the Central Nervous System Principles and Practice in Drug Development Massachusetts Institute of Technology, Estados Unidos
2011/11/09 - 2011/11/09 Terapia génica. Programa Doutoral em Ciências da Saúde Universidade de Coimbra Faculdade de Medicina, Portugal
2011/10/24 - 2011/10/28 Modeling and modifying Machado-Joseph progression. Programa Doutoral em Biologia Experimental e Biomedicina (PDBEB) Universidade de Coimbra Centro de Neurociências e Biologia Celular, Portugal
2011/09/26 - 2011/09/26 Vectors for Gene Therapy. Programa de doutoramento em ciências da saúde Universidade de Coimbra Faculdade de Medicina, Portugal
2011/06/01 - 2011/06/01 Terapia génica do sistema nervoso. Mestrado em Regulação e Avaliação do Medicamento e Produtos de Saúde Universidade de Lisboa Faculdade de Farmácia, Portugal
2011/05/20 - 2011/05/20 Doenças de Huntington e Machado-Joseph: Estratégias de terapia molecular. Mestrado em Farmacologia aplicada Universidade de Coimbra Faculdade de Farmácia, Portugal
2011/04/15 - 2011/04/15 Terapia génica do sistema nervoso. Universidade do Algarve, Portugal
2011/03/30 - 2011/03/30 Terapia génica da doença de Machado-Joseph. Universidade de Coimbra Faculdade de Farmácia, Portugal
2010/07/15 - 2010/07/21 Gene therapy in neurodegeneration Workshop “Molecular Mechanisms in Neurodegeneration: From Molecule to Cures" Harvard Medical School Portugal- Program in Translational Research and information
2010/05/29 - 2010/05/30 shRNAs for silencing Machado-Joseph's disease; Workshop: "Novel Experimental Therapies for Diseases of the Nervous System". Harvard Medical School Portugal- Program in Translational Research and information
2009/11/19 - 2009/11/19 Gene Therapy as a strategy of drug delivery to the Central Nervous System Principles and Pratice in Drug Development Massachusetts Institute of Technology, Estados Unidos
2008/06/08 - 2008/06/10 From the frying pan into the brain: lipoplexes for CNS gene delivery. Gene Therapy Workshop NeuroNE Workshop
2007/10/25 - 2007/10/25 Gene Therapy as a strategy of drug delivery to the Central Nervous System Principles of Drug Development Universidade de Lisboa Instituto Superior Técnico, Portugal
2007/10/11 - 2007/10/11 Gene Therapy as a strategy of drug delivery to the Central Nervous System Principles of Drug Development Massachusetts Institute of Technology, Estados Unidos